CAMK2A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O00631 | T5 | SIGNOR|EPSD|PSP | SLN | ________________MGINtRELFLNFTIVLITVILMWLL |
| O14490 | S356 | SIGNOR | DLGAP1 DAP1 GKAP | EIPCRRMRSGsYIKAMGDEDsGDsDtsPKPsPKVAARREsY |
| O14713 | T38 | SIGNOR|iPTMNet|EPSD|PSP | ITGB1BP1 ICAP1 | EISTKSKsVDssLGGLsRsstVAsLDTDSTKssGQSNNNSD |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15143 | S310 | Sugiyama | ARPC1B ARC41 | QSSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVs |
| O15143 | S311 | Sugiyama | ARPC1B ARC41 | SSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVsQ |
| O15273 | S157 | EPSD|PSP | TCAP | TKQLPPVVPVSKPGALRRSLsRSMsQEAQRG__________ |
| O15273 | S161 | EPSD|PSP | TCAP | PPVVPVSKPGALRRSLsRSMsQEAQRG______________ |
| O43164 | S253 | Sugiyama | PJA2 KIAA0438 RNF131 | LDsVPLVKssAGDTEFVHQNsQEIQRSSQDEMVSTKQQNNT |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43399 | S166 | Sugiyama | TPD52L2 | tVGsAIsRKLGDMRNsAtFKsFEDRVGtIKSKVVGDRENGs |
| O43399 | T163 | Sugiyama | TPD52L2 | ALstVGsAIsRKLGDMRNsAtFKsFEDRVGtIKSKVVGDRE |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43823 | S399 | Sugiyama | AKAP8 AKAP95 | RTRDRAADRIQFACSVCKFRsFDDEEIQKHLQSKFHKETLR |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60266 | S1076 | ELM | ADCY3 KIAA0511 | ARKPHYDIWGNTVNVASRMEsTGVMGNIQVVEETQVILREY |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S178 | Sugiyama | EIF5B IF2 KIAA0741 | NKKWDGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRK |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O75469 | T290 | PSP | NR1I2 PXR | EDQIsLLKGAAFELCQLRFNtVFNAETGTWECGRLsYCLED |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O95071 | S327 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | LLRERESVLRLRERRWLDGAsFDNERGSTSKEGEPNLDKKN |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95180 | S1198 | PSP | CACNA1H | EAEDGRAAPGPRATPLRRAEsLDPRPLRPAALPPTKCRDRD |
| O95180 | S2137 | SIGNOR | CACNA1H | PHGPEASPVAGGERDLRRLYsVDAQGFLDKPGRADEQWRPS |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95425 | S914 | Sugiyama | SVIL | LRTKPPLDHNAsAtDYKFSssIENsDsPVRSILKSQAWQPL |
| O95425 | S968 | Sugiyama | SVIL | GETESKRALTGRDSGMEKyGsFEEAEASYPILNRAREGDSH |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95997 | S31 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | NGEPGTRVVAKDGLKLGsGPsIKALDGRSQVSTPRFGKTFD |
| O95997 | S87 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | VNRATEKSVKTKGPLKQKQPsFsAKKMTEKTVKAKSSVPAS |
| O95997 | S89 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | RATEKSVKTKGPLKQKQPsFsAKKMTEKTVKAKSSVPASDD |
| O95997 | T66 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | FGKTFDAPPALPKAtRKALGtVNRATEKSVKTKGPLKQKQP |
| O96013 | S41 | Sugiyama | PAK4 KIAA1142 | VHTGFDQHEQKFTGLPRQWQsLIEESARRPKPLVDPACITS |
| P00533 | S1064 | SIGNOR|iPTMNet | EGFR ERBB ERBB1 HER1 | NstVACIDRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDD |
| P00533 | S1070 | SIGNOR|ELM|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | IDRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPVP |
| P00533 | S1071 | SIGNOR|ELM|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | DRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPVPE |
| P00533 | S1081 | SIGNOR|ELM|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | KEDsFLQRyssDPtGALtEDsIDDtFLPVPEyINQsVPKRP |
| P00533 | S1120 | SIGNOR|iPTMNet | EGFR ERBB ERBB1 HER1 | RPAGsVQNPVyHNQPLNPAPsRDPHyQDPHstAVGNPEyLN |
| P00533 | S1166 | SIGNOR|ELM|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | CVNSTFDsPAHWAQKGsHQIsLDNPDyQQDFFPKEAKPNGI |
| P00533 | S768 | SIGNOR|ELM|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | REATSPKANKEILDEAyVMAsVDNPHVCRLLGICLTSTVQL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04626 | T1172 | ELM|EPSD | ERBB2 HER2 MLN19 NEU NGL | PREGPLPAARPAGAtLERPKtLSPGKNGVVKDVFAFGGAVE |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05423 | S250 | Sugiyama | POLR3D BN51 BN51T | AKMKAPPKAARKTPGLPKDVsVAELLRELSLTKEEELLFLQ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05556 | T788 | EPSD|PSP | ITGB1 FNRB MDF2 MSK12 | KEKMNAKWDtGENPIyKsAVttVVNPKyEGK__________ |
| P05556 | T789 | EPSD|PSP | ITGB1 FNRB MDF2 MSK12 | EKMNAKWDtGENPIyKsAVttVVNPKyEGK___________ |
| P05783 | S53 | SIGNOR|ELM|iPTMNet | KRT18 CYK18 PIG46 | AsVyAGAGGsGsRIsVsRstsFRGGMGsGGLAtGIAGGLAG |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P07101 | S19 | SIGNOR|ELM|EPSD|PSP | TH TYH | __MPTPDATTPQAKGFRRAVsELDAKQAEAIMVRGQGAPGP |
| P07101 | S71 | ELM|EPSD|PSP | TH TYH | APAASYTPTPRsPRFIGRRQsLIEDARKEREAAVAAAAAAV |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S747 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVREL |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08670 | S83 | ELM|EPSD|PSP | VIM | tRssAVRLRssVPGVRLLQDsVDFsLADAINTEFKNTRTNE |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09234 | S48 | Sugiyama | SNRPC | RKHKENVKDYYQKWMEEQAQsLIDKTTAAFQQGKIPPTPFS |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09417 | S223 | ELM | QDPR DHPR SDR33C1 | TPLEFLVETFHDWITGKNRPsSGsLIQVVTTEGRTELTPAY |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09917 | S272 | SIGNOR|ELM|EPSD|PSP | ALOX5 LOG5 | LPEKLPVtTEMVECSLERQLsLEQEVQQGNIFIVDFELLDG |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10636 | S552 | SIGNOR | MAPT MAPTL MTBT1 TAU | LPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMPDLKN |
| P10636 | S579 | SIGNOR | MAPT MAPTL MTBT1 TAU | RLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQIINKKL |
| P10636 | T548 | SIGNOR | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11717 | S1378 | Sugiyama | IGF2R MPRI | QYACPPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTG |
| P11831 | S103 | SIGNOR|iPTMNet|EPSD|PSP | SRF | sEsGEEEELGAERRGLKRsLsEMEIGMVVGGPEASAAATGG |
| P11831 | T160 | GPS6|SIGNOR|iPTMNet | SRF | TRGRVKIKMEFIDNKLRRYttFsKRKTGIMKKAYELSTLTG |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13073 | S89 | Sugiyama | COX4I1 COX4 | SWssLsMDEKVELYRIKFKEsFAEMNRGSNEWKTVVGGAMF |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P14136 | S13 | SIGNOR|ELM|iPTMNet | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S17 | SIGNOR|ELM|iPTMNet | GFAP | ____MERRRItsAARRsYVssGEMMVGGLAPGRRLGPGTRL |
| P14136 | S38 | SIGNOR|ELM|iPTMNet | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14136 | S393 | SIGNOR|iPTMNet | GFAP | EENRITIPVQTFSNLQIRETsLDTKSVSEGHLKRNIVVKTV |
| P14921 | S251 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ETS1 EWSR2 | VTPDNMCMGRTSRGKLGGQDsFEsIEsYDSCDRLtQsWssQ |
| P14921 | S257 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ETS1 EWSR2 | CMGRTSRGKLGGQDsFEsIEsYDSCDRLtQsWssQssFNsL |
| P14921 | S282 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ETS1 EWSR2 | DRLtQsWssQssFNsLQRVPsyDsFDsEDYPAALPNHKPKG |
| P14921 | S285 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ETS1 EWSR2 | tQsWssQssFNsLQRVPsyDsFDsEDYPAALPNHKPKGTFK |
| P15036 | S246 | SIGNOR|EPSD|PSP | ETS2 | TPSVLSSEQEFQMFPKSRLSsVsVTYCSVsQDFPGSNLNLL |
| P15036 | S310 | SIGNOR|EPSD|PSP | ETS2 | DSLLQSWNSQSSLLDVQRVPsFEsFEDDCsQSLCLNKPTMS |
| P15036 | S313 | SIGNOR|EPSD|PSP | ETS2 | LQSWNSQSSLLDVQRVPsFEsFEDDCsQSLCLNKPTMSFKD |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S536 | Sugiyama | EZR VIL2 | KRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNE |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16070 | S706 | SIGNOR|EPSD|PSP | CD44 LHR MDU2 MDU3 MIC4 | sGNGAVEDRKPsGLNGEAsKsQEMVHLVNKEssEtPDQFMt |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16220 | S142 | SIGNOR|ELM | CREB1 | KILNDLssDAPGVPRIEEEKsEEETSAPAITTVTVPTPIYQ |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16615 | S38 | SIGNOR|ELM|iPTMNet | ATP2A2 ATP2B | VNESTGLSLEQVKKLKERWGsNELPAEEGKTLLELVIEQFE |
| P16949 | S16 | SIGNOR|EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17676 | S325 | SIGNOR|ELM|iPTMNet | CEBPB TCF5 PP9092 | ELTAENERLQKKVEQLSRELsTLRNLFKQLPEPLLAssGHC |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20941 | S54 | SIGNOR|iPTMNet | PDC | LESQDSDSIPPSKKEILRQMsSPQSRNGKDSKERVSRKMsI |
| P20941 | S73 | SIGNOR|iPTMNet | PDC | MsSPQSRNGKDSKERVSRKMsIQEYELIHKEKEDENCLRKY |
| P21333 | S2523 | ELM|EPSD|PSP | FLNA FLN FLN1 | GPYHIGGsPFKAKVTGPRLVsNHsLHEtsSVFVDsLtKATC |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S131 | Sugiyama | EIF4B | SIKEFFRGLNIsAVRLPREPsNPERLKGFGyAEFEDLDSLL |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P23677 | T311 | SIGNOR|ELM|EPSD|PSP | ITPKA | KMLAVDPEAPTEEEHAQRAVtKPRYMQWREGISSSTTLGFR |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24588 | S92 | EPSD|PSP | AKAP5 AKAP79 | PEPTRGAWAsLKRLVtRRKRsESSKQQKPLEGEMQPAINAE |
| P24588 | T87 | EPSD|PSP | AKAP5 AKAP79 | GASDQPEPTRGAWAsLKRLVtRRKRsESSKQQKPLEGEMQP |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26639 | T704 | Sugiyama | TARS1 TARS | GTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEEF_ |
| P26641 | S286 | Sugiyama | EEF1G EF1G PRO1608 | CEQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVA |
| P26678 | T17 | EPSD|PSP | PLN PLB | ____MEKVQYLTRSAIRRAstIEMPQQARQKLQNLFINFCL |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28329 | T574 | SIGNOR | CHAT | YESAsIRRFQEGRVDNIRSAtPEALAFVRAVTDHKAAVPAs |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29475 | S852 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | NOS1 | EMRHPNSVQEERKSYKVRFNsVSSYSDsQKSSGDGPDLRDN |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P30040 | T62 | Sugiyama | ERP29 C12orf8 ERP28 | DtVtFyKVIPKSKFVLVKFDtQyPyGEKQDEFKRLAENSAS |
| P30043 | T190 | Sugiyama | BLVRB FLR SCAN | RGPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ____ |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | S247 | Sugiyama | LRPAP1 A2MRAP | KLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSA |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P30626 | S111 | Sugiyama | SRI | GFNEFKELWAVLNGWRQHFIsFDTDRSGTVDPQELQKALtt |
| P31327 | S537 | Sugiyama | CPS1 | GVELFKRGVLKEYGVKVLGtsVEsIMATEDRQLFSDKLNEI |
| P31645 | S13 | EPSD|PSP | SLC6A4 HTT SERT | ________METTPLNSQKQLsACEDGEDCQENGVLQKVVPT |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P35222 | S552 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AIPRLVQLLVRAHQDtQRRtsMGGtQQQFVEGVRMEEIVEG |
| P35222 | T332 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | KLIILASGGPQALVNIMRTytyEKLLWTTSRVLKVLSVCSs |
| P35222 | T472 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | LRAGDREDITEPAICALRHLtSRHQEAEMAQNAVRLHyGLP |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35270 | S213 | EPSD|PSP | SPR | VLNYAPGPLDTDMQQLARETsVDPDMRKGLQELKAKGKLVD |
| P35367 | S396 | ELM|EPSD|PSP | HRH1 | LRsGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQ |
| P35367 | S398 | SIGNOR|ELM|EPSD|PSP | HRH1 | sGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQLG |
| P35367 | T140 | SIGNOR|ELM|EPSD|PSP | HRH1 | ILCIDRYRSVQQPLRYLKYRtKtRASATILGAWFLSFLWVI |
| P35367 | T142 | ELM|EPSD|PSP | HRH1 | CIDRYRSVQQPLRYLKYRtKtRASATILGAWFLSFLWVIPI |
| P35372 | S268 | SIGNOR|EPSD|PSP | OPRM1 MOR1 | LIITVCYGLMILRLKSVRMLsGsKEKDRNLRRITRMVLVVV |
| P35372 | S270 | SIGNOR | OPRM1 MOR1 | ITVCYGLMILRLKSVRMLsGsKEKDRNLRRITRMVLVVVAV |
| P35372 | T372 | SIGNOR | OPRM1 MOR1 | FCIPtssNIEQQNsTRIRQNtRDHPstANtVDRTNHQLENL |
| P35637 | S340 | Sugiyama | FUS TLS | PMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFs |
| P35637 | T338 | Sugiyama | FUS TLS | GQPMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKE |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37840 | S129 | EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40189 | S782 | PSP | IL6ST | VVHSGyRHQVPSVQVFSRsEstQPLLDSEERPEDLQLVDHV |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41091 | T464 | Sugiyama | EIF2S3 EIF2G | SRRVEKHWRLIGWGQIRRGVtIKPtVDDD____________ |
| P41091 | T468 | Sugiyama | EIF2S3 EIF2G | EKHWRLIGWGQIRRGVtIKPtVDDD________________ |
| P41134 | S36 | SIGNOR|EPSD|PSP | ID1 BHLHB24 ID | SCALKAGKTASGAGEVVRCLsEQSVAISRCAGGAGARLPAL |
| P41236 | S24 | Sugiyama | PPP1R2 IPP2 | STAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSKKs |
| P42261 | S567 | EPSD|PSP | GRIA1 GLUA1 GLUH1 GLUR1 | YIGVSVVLFLVSRFSPYEWHsEEFEEGRDQTTSDQSNEFGI |
| P42261 | S849 | ELM | GRIA1 GLUA1 GLUH1 GLUR1 | CYKsRsEsKRMKGFCLIPQQsINEAIRTStLPRNsGAGASS |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P43003 | T26 | EPSD|PSP | SLC1A3 EAAT1 GLAST GLAST1 | GEEPKMGGRMERFQQGVRKRtLLAKKKVQNItKEDVKSYLF |
| P43003 | T37 | EPSD|PSP | SLC1A3 EAAT1 GLAST GLAST1 | RFQQGVRKRtLLAKKKVQNItKEDVKSYLFRNAFVLLTVTA |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43034 | S157 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | yEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADMTIKLW |
| P43034 | S399 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | HEHFVTSLDFHKTAPYVVTGsVDQTVKVWECR_________ |
| P43034 | T150 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | ATIKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSA |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46013 | S1098 | Sugiyama | MKI67 | PAARVTGMKKWPRtPKEEAQsLEDLAGFKELFQtPGPsEEs |
| P46013 | T1764 | Sugiyama | MKI67 | LVDtPtssKPQPKRSLRKADtEEEFLAFRKQTPSAGKAMHt |
| P46527 | S10 | EPSD|PSP | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46937 | T110 | Sugiyama | YAP1 YAP65 | KLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPA |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P47712 | S515 | ELM|EPSD | PLA2G4A CPLA2 PLA2G4 | GLNLNTSYPLsPLSDFATQDsFDDDELDAAVADPDEFERIy |
| P48058 | S862 | SIGNOR | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51790 | S109 | SIGNOR|EPSD|PSP | CLCN3 | HTIDWVREKCKDRERHRRINsKKKESAWEMTKSLYDAWSGW |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52272 | S618 | Sugiyama | HNRNPM HNRPM NAGR1 | PALGAGIERMGLAMGGGGGAsFDRAIEMERGNFGGsFAGsF |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P53999 | S56 | Sugiyama | SUB1 PC4 RPO2TC1 | PVKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRD |
| P55042 | S273 | EPSD|PSP | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55055 | S426 | EPSD | NR1H2 LXRB NER UNR | TRIKRPQDQLRFPRMLMKLVsLRTLsSVHSEQVFALRLQDK |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P55081 | S133 | Sugiyama | MFAP1 | VGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMMR |
| P55081 | S94 | Sugiyama | MFAP1 | EEQEEDsssDPRLRRLQNRIsEDVEERLARHRKIVEPEVVG |
| P55769 | S122 | Sugiyama | SNU13 NHP2L1 | CSVTIKEGSQLKQQIQsIQQsIERLLV______________ |
| P60174 | S198 | Sugiyama | TPI1 TPI | TPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtC |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62258 | T232 | Sugiyama | YWHAE | EsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQDVED |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T226 | Sugiyama | YWHAZ | LsEEsyKDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_ |
| P63167 | S14 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | _______MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNI |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P78352 | S73 | PSP | DLG4 PSD95 | QVNGTEGEMEYEEITLERGNsGLGFSIAGGTDNPHIGDDPS |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00613 | S230 | SIGNOR|ELM|iPTMNet|EPSD|PSP | HSF1 HSTF1 | PLMLNDsGsAHSMPKYSRQFsLEHVHGSGPYSAPSPAYSSS |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q00975 | S2120 | SIGNOR | CACNA1B CACH5 CACNL1A5 | RERERRQERGRSQERRQPSSsSSEKQRFYSCDRFGGREPPK |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01970 | S537 | ELM|EPSD|PSP | PLCB3 | PGLSNGEEVGLEKPSLEPQKsLGDEGLNRGPyVLGPADRED |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02952 | S648 | Sugiyama | AKAP12 AKAP250 | EsDKEDELDKVKsAtLsstEstAsEMQEEMKGsVEEPKPEE |
| Q04637 | S1238 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | RDAVKREAALPPVsPLKAALsEEELEKKsKAIIEEyLHLND |
| Q04760 | T107 | SIGNOR|EPSD|PSP | GLO1 | EKIAWALSRKATLELTHNWGtEDDEtQsyHNGNsDPRGFGH |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q05397 | S843 | SIGNOR | PTK2 FAK FAK1 | QRWLEKEERFLKPDVRLsRGsIDREDGsLQGPIGNQHIyQP |
| Q05469 | S855 | SIGNOR | LIPE | SGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKNLT |
| Q05682 | S643 | SIGNOR | CALD1 CAD CDM | PEDGLsDDKKPFKCFTPKGSsLKIEERAEFLNKsVQKsSGV |
| Q05682 | S656 | SIGNOR | CALD1 CAD CDM | CFTPKGSsLKIEERAEFLNKsVQKsSGVKSTHQAAIVSKID |
| Q06210 | S261 | SIGNOR|EPSD|PSP|Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1051 | Sugiyama | TJP1 ZO1 | PDKEPNLTyEPQLPYVEKQAsRDLEQPtyRyEsssytDQFs |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q08945 | S657 | Sugiyama | SSRP1 FACT80 | MEKKSTPSRGsSSKSsSRQLsEsFKSKEFVssDEsssGENK |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q12830 | S1310 | Sugiyama | BPTF FAC1 FALZ | DRVLDDVsIRsPEtKCPKQNsIENDIEEKVSDLASRGQEPS |
| Q12879 | S1291 | iPTMNet | GRIN2A NMDAR2A | WAQNNALQLQKNKLRISRQHsyDNIVDKPRELDLSRPSRSI |
| Q12879 | S1459 | PSP | GRIN2A NMDAR2A | YSTPRVLNSCSNRRVYKKMPsIESDV_______________ |
| Q12959 | S232 | SIGNOR|ELM|iPTMNet | DLG1 | YVNGTDADYEYEEITLERGNsGLGFSIAGGTDNPHIGDDSS |
| Q13206 | S831 | Sugiyama | DDX10 | DMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWDTL |
| Q13224 | S1303 | SIGNOR|iPTMNet|EPSD|PSP | GRIN2B NMDAR2B | QSPTNSKAQKKNRNKLRRQHsYDTFVDLQKEEAALAPRSVs |
| Q13224 | S383 | iPTMNet | GRIN2B NMDAR2B | VIILLNKERKWERVGKWKDKsLQMKYYVWPRMCPETEEQED |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13554 | S26 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | TCTRFTDEYQLYEDIGKGAFsVVRRCVKLCTGHEYAAKIIN |
| Q13554 | T306 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | EtVECLKKFNARRKLKGAILttMLAtRNFSVGRQTtAPAtM |
| Q13554 | T307 | Sugiyama | CAMK2B CAM2 CAMK2 CAMKB | tVECLKKFNARRKLKGAILttMLAtRNFSVGRQTtAPAtMS |
| Q13555 | S26 | Sugiyama | CAMK2G CAMK CAMK-II CAMKG | TCTRFTDDYQLFEELGKGAFsVVRRCVKKTstQEYAAKIIN |
| Q13557 | S26 | Sugiyama | CAMK2D CAMKD | TCTRFTDEyQLFEELGKGAFsVVRRCMKIPTGQEYAAKIIN |
| Q13557 | T306 | Sugiyama | CAMK2D CAMKD | EtVDCLKKFNARRKLKGAILttMLAtRNFsAAKsLLKKPDG |
| Q13557 | T307 | Sugiyama | CAMK2D CAMKD | tVDCLKKFNARRKLKGAILttMLAtRNFsAAKsLLKKPDGV |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q13698 | S1575 | SIGNOR | CACNA1S CACH1 CACN1 CACNL1A3 | IQAGLRTIEEEAAPEICRtVsGDLAAEEELERAMVEAAMEE |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14151 | S613 | Sugiyama | SAFB2 KIAA0138 | ERSSKSQDRKSESKEKRDILsFDKIKEQRERERQRQREREI |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | T239 | Sugiyama | UBAP2L KIAA0144 NICE4 | GNTWNNTGHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIF |
| Q14157 | T241 | Sugiyama | UBAP2L KIAA0144 NICE4 | TWNNTGHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtA |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14444 | S307 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | SEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNSL |
| Q14457 | S90 | EPSD|PSP | BECN1 GT197 | IETPRQDGVSRRFIPPARMMsTEsANsFTLIGEASDGGtME |
| Q14457 | S93 | PSP | BECN1 GT197 | PRQDGVSRRFIPPARMMsTEsANsFTLIGEASDGGtMENLS |
| Q14457 | S96 | PSP | BECN1 GT197 | DGVSRRFIPPARMMsTEsANsFTLIGEASDGGtMENLSRRL |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14524 | S1003 | PSP | SCN5A | GLLRQRPQKPAALAAQGQLPsCIATPYSPPPPETEKVPPTR |
| Q14524 | S11 | PSP | SCN5A | __________MANFLLPRGTssFRRFtREsLAAIEKRMAEK |
| Q14524 | S12 | PSP | SCN5A | _________MANFLLPRGTssFRRFtREsLAAIEKRMAEKQ |
| Q14524 | S1503 | PSP | SCN5A | QDIFMTEEQKKyyNAMKKLGsKKPQKPIPRPLNKYQGFIFD |
| Q14524 | S1865 | PSP | SCN5A | GDRIHCMDILFAFTKRVLGEsGEMDALKIQMEEKFMAANPs |
| Q14524 | S1885 | PSP | SCN5A | sGEMDALKIQMEEKFMAANPsKISYEPITTTLRRKHEEVSA |
| Q14524 | S1920 | PSP | SCN5A | HEEVSAMVIQRAFRRHLLQRsLKHAsFLFRQQAGsGLsEED |
| Q14524 | S1925 | PSP | SCN5A | AMVIQRAFRRHLLQRsLKHAsFLFRQQAGsGLsEEDAPERE |
| Q14524 | S1934 | PSP | SCN5A | RHLLQRsLKHAsFLFRQQAGsGLsEEDAPEREGLIAYVMSE |
| Q14524 | S1937 | PSP | SCN5A | LQRsLKHAsFLFRQQAGsGLsEEDAPEREGLIAYVMSENFS |
| Q14524 | S1998 | PSP | SCN5A | DSVTRATsDNLQVRGSDYSHsEDLADFPPsPDRDRESIV__ |
| Q14524 | S20 | PSP | SCN5A | _MANFLLPRGTssFRRFtREsLAAIEKRMAEKQARGsTTLQ |
| Q14524 | S2007 | PSP | SCN5A | NLQVRGSDYSHsEDLADFPPsPDRDRESIV___________ |
| Q14524 | S42 | PSP | SCN5A | AAIEKRMAEKQARGsTTLQEsREGLPEEEAPRPQLDLQAsK |
| Q14524 | S457 | PSP | SCN5A | AMEMLKKEHEALTIRGVDtVsRssLEMsPLAPVNsHERRSK |
| Q14524 | S460 | PSP | SCN5A | MLKKEHEALTIRGVDtVsRssLEMsPLAPVNsHERRSKRRK |
| Q14524 | S464 | PSP | SCN5A | EHEALTIRGVDtVsRssLEMsPLAPVNsHERRSKRRKRMss |
| Q14524 | S471 | PSP | SCN5A | RGVDtVsRssLEMsPLAPVNsHERRSKRRKRMssGtEECGE |
| Q14524 | S483 | PSP | SCN5A | MsPLAPVNsHERRSKRRKRMssGtEECGEDRLPKsDsEDGP |
| Q14524 | S484 | PSP | SCN5A | sPLAPVNsHERRSKRRKRMssGtEECGEDRLPKsDsEDGPR |
| Q14524 | S497 | PSP | SCN5A | KRRKRMssGtEECGEDRLPKsDsEDGPRAMNHLsLTRGLsR |
| Q14524 | S499 | PSP | SCN5A | RKRMssGtEECGEDRLPKsDsEDGPRAMNHLsLTRGLsRTS |
| Q14524 | S510 | PSP | SCN5A | GEDRLPKsDsEDGPRAMNHLsLTRGLsRTSMKPRssRGsIF |
| Q14524 | S516 | SIGNOR|PSP | SCN5A | KsDsEDGPRAMNHLsLTRGLsRTSMKPRssRGsIFTFRRRD |
| Q14524 | S528 | PSP | SCN5A | HLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFADDEN |
| Q14524 | S539 | PSP | SCN5A | SMKPRssRGsIFTFRRRDLGsEADFADDENSTAGESESHHT |
| Q14524 | S571 | SIGNOR|PSP | SCN5A | AGESESHHTSLLVPWPLRRtsAQGQPsPGTSAPGHALHGKK |
| Q14524 | S577 | PSP | SCN5A | HHTSLLVPWPLRRtsAQGQPsPGTSAPGHALHGKKNStVDC |
| Q14524 | S61 | PSP | SCN5A | EsREGLPEEEAPRPQLDLQAsKKLPDLYGNPPQELIGEPLE |
| Q14524 | S664 | PSP | SCN5A | TSQAPCVDGFEEPGARQRALsAVsVLtsALEELEESRHKCP |
| Q14524 | S667 | PSP | SCN5A | APCVDGFEEPGARQRALsAVsVLtsALEELEESRHKCPPCW |
| Q14524 | T17 | PSP | SCN5A | ____MANFLLPRGTssFRRFtREsLAAIEKRMAEKQARGsT |
| Q14524 | T455 | PSP | SCN5A | QEAMEMLKKEHEALTIRGVDtVsRssLEMsPLAPVNsHERR |
| Q14524 | T570 | PSP | SCN5A | TAGESESHHTSLLVPWPLRRtsAQGQPsPGTSAPGHALHGK |
| Q14524 | T594 | SIGNOR | SCN5A | GQPsPGTSAPGHALHGKKNStVDCNGVVSLLGAGDPEATSP |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14654 | T180 | EPSD|PSP | KCNJ11 | NAIMLGCIFMKTAQAHRRAEtLIFSKHAVIALRHGRLCFML |
| Q14654 | T224 | EPSD|PSP | KCNJ11 | DLRKSMIISATIHMQVVRKTtSPEGEVVPLHQVDIPMENGV |
| Q14674 | S1501 | EPSD|PSP | ESPL1 ESP1 KIAA0165 | GPEIMRTIPEEELTDNWRKMsFEILRGsDGEDsASGGKTPA |
| Q14677 | S163 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | DRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14684 | S422 | Sugiyama | RRP1B KIAA0179 | KKKKKHHLQPENPGPGGAAPsLEQNRGREPEASGLKALKAR |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14847 | S146 | Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14966 | S1228 | Sugiyama | ZNF638 NP220 ZFML | DLEKKGAEIINPKTALLPSDsVFAEERNLKGILEEsPsEAE |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15121 | S116 | SIGNOR|ELM | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15398 | T54 | Sugiyama | DLGAP5 DLG7 KIAA0008 | NRHKEYERNRHFGLKDVNIPtLEGRILVELDETsQGLVPEK |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q15796 | S110 | SIGNOR|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | PNTIDQWDTTGLYSFSEQTRsLDGRLQVSHRKGLPHVIyCR |
| Q15796 | S240 | SIGNOR|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | tPPPGYISEDGETSDQQLNQsMDtGsPAELsPTTLsPVNHs |
| Q15796 | S260 | SIGNOR|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | sMDtGsPAELsPTTLsPVNHsLDLQPVTYSEPAFWCSIAYY |
| Q15906 | T137 | ELM | VPS72 TCFL1 YL1 | LLPLELQDDGsDsRKsMRQStAEHTRQTFLRVQERQGQSRR |
| Q15906 | T168 | ELM | VPS72 TCFL1 YL1 | VQERQGQSRRRKGPHCERPLtQEELLREAKITEELNLRSLE |
| Q15906 | T86 | ELM | VPS72 TCFL1 YL1 | GDEPSsDGEAEEPRRKRRVVtKAYKEPLKSLRPRKVNTPAG |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16626 | S163 | Sugiyama | MEA1 MEA | RTMAGVSLPAPGVPAWAREIsDAQWEDVVQKALQARQAsPA |
| Q27J81 | S1194 | Sugiyama | INF2 C14orf151 C14orf173 | EDEEDtAPEsALDtsLDKsFsEDAVtDssGsGtLPRARGRA |
| Q2VIR3 | T464 | Sugiyama | EIF2S3B | SRRVEKHWRLIGWGQIRRGVtIKPtVDDD____________ |
| Q2VIR3 | T468 | Sugiyama | EIF2S3B | EKHWRLIGWGQIRRGVtIKPtVDDD________________ |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q4G163 | S192 | SIGNOR | FBXO43 EMI2 | QNSSLESSISQVINLEKNIPsSASGFSRANNFSPLVTSTLK |
| Q4G163 | T234 | EPSD|PSP | FBXO43 EMI2 | EEVTSCSQKLRLNFSQQKTStIDDSKDDCSLFEVECISPIQ |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5VT52 | S1177 | Sugiyama | RPRD2 KIAA0460 HSPC099 | GGLTGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPs |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q69YH5 | S205 | Sugiyama | CDCA2 | LSACQQSGFPAVLssKRRRIsYQRDsDENLTDAEGKVIGLQ |
| Q69YH5 | S210 | Sugiyama | CDCA2 | QSGFPAVLssKRRRIsYQRDsDENLTDAEGKVIGLQIFNID |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7L2E3 | S226 | Sugiyama | DHX30 DDX30 KIAA0890 | DFLSMTQQDSHAPLRDSRGssFEMTDDDSAIRALTQFPLPK |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z4V5 | S396 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKP |
| Q7Z4V5 | S399 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQSS |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86UR5 | S242 | SIGNOR | RIMS1 KIAA0340 RAB3IP2 RIM1 Nbla00761 | LSTAAASSQDAAPPSAPPDRsKGAEPSQQALGPEQKQASSR |
| Q86UR5 | S288 | SIGNOR | RIMS1 KIAA0340 RAB3IP2 RIM1 Nbla00761 | PRERKKTPGLSEQNGKGALKsERKRVPKTSAQPVEGAVEER |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N6H7 | S368 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | VGTFASGPPKYKDNPFsLGEsFGsRWDTDAAWGMDRVEEKE |
| Q8N6H7 | S432 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | RssGLEssEARQKFAGAKAIssDMFFGREVDAEyEARSRLQ |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8NE71 | S140 | Sugiyama | ABCF1 ABC50 | PRGGKKTKGGNVFAALIQDQsEEEEEEEKHPPKPAKPEKNR |
| Q8NE71 | S166 | Sugiyama | ABCF1 ABC50 | EEKHPPKPAKPEKNRINKAVsEEQQPALKGKKGKEEKSKGK |
| Q8NE71 | T108 | Sugiyama | ABCF1 ABC50 | VDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKG |
| Q8NHV4 | S396 | Sugiyama | NEDD1 | RsINTDtLSKEtDsGKNQDFssFDDtGKssLGDMFsPIRDD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TEQ6 | S757 | Sugiyama | GEMIN5 | PKAKPKKKKKPTLRtPVKLEsIDGNEEEsMKENsGPVENGV |
| Q8WWI1 | S805 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | LQDRESQNQKSTVPSRRRMysFDDVLEEGKRPPtMtVSEAS |
| Q8WWI1 | T932 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VtPRPFGsQtRGISsLPRsYtMDDAWKYNGDVEDIKRtPNN |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q92736 | S2808 | ELM|EPSD|PSP | RYR2 | RIERTREGDSMALYNRTRRIsQTSQVsVDAAHGYSPRAIDM |
| Q92736 | S2814 | EPSD|PSP | RYR2 | EGDSMALYNRTRRIsQTSQVsVDAAHGYSPRAIDMSNVTLS |
| Q92804 | S289 | Sugiyama | TAF15 RBP56 TAF2N | PMINLYTDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFH |
| Q92804 | T287 | Sugiyama | TAF15 RBP56 TAF2N | GKPMINLYTDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKE |
| Q96A00 | S130 | ELM|EPSD|PSP | PPP1R14A CPI17 PPP1INL | ELLAKLQGLHRQPGLRQPsPsHDGsLsPLQDRARTAHP___ |
| Q96AT1 | S146 | Sugiyama | KIAA1143 | VNQDsVKKNSQKQIKNssLLsFDNEDENE____________ |
| Q96CT7 | S141 | Sugiyama | CCDC124 | KsHLEVPLEENVNRRVLEEGsVEARTIEDAIAVLsVAEEAA |
| Q96E11 | S239 | Sugiyama | MRRF | LKKSKDTVsEDtIRLIEKQIsQMADDtVAELDRHLAVKTKE |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q96NW7 | S1439 | SIGNOR|iPTMNet | LRRC7 KIAA1365 LAP1 | SQATRGPQPGRCLIQTKGQRsMDGYPEQFCVRIEKNPGLGF |
| Q96PH1 | S521 | SIGNOR | NOX5 | KDTIWLHIRSQGQWTNRLYEsFKASDPLGRGSKRLsRSVtM |
| Q96PH1 | S544 | SIGNOR | NOX5 | ASDPLGRGSKRLsRSVtMRKsQRssKGSEILLEKHKFCNIK |
| Q96PH1 | S547 | SIGNOR | NOX5 | PLGRGSKRLsRSVtMRKsQRssKGSEILLEKHKFCNIKCYI |
| Q96PH1 | S548 | SIGNOR | NOX5 | LGRGSKRLsRSVtMRKsQRssKGSEILLEKHKFCNIKCYID |
| Q96PH1 | T540 | SIGNOR | NOX5 | EsFKASDPLGRGSKRLsRSVtMRKsQRssKGSEILLEKHKF |
| Q96PM5 | S155 | SIGNOR|EPSD|PSP | RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363 | KCIENVSRQNCPICLEDIHtsRVVAHVLPCGHLLHRTCYEE |
| Q96PM5 | T154 | SIGNOR|EPSD|PSP | RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363 | HKCIENVSRQNCPICLEDIHtsRVVAHVLPCGHLLHRTCYE |
| Q96PV0 | S1073 | SIGNOR|iPTMNet | SYNGAP1 KIAA1938 | SGGGSGGGGGGQPPPLQRGKsQQLtVSAAQKPRPSSGNLLQ |
| Q96PV0 | S1138 | SIGNOR|iPTMNet | SYNGAP1 KIAA1938 | SGGSGGGGGGGLKPSITKQHsQTPSTLNPTMPASERTVAWV |
| Q96PV0 | S779 | SIGNOR | SYNGAP1 KIAA1938 | MMRDLNSSIDLQSFMARGLNssMDMARLPSPTKEKPPPPPP |
| Q96PV0 | S780 | SIGNOR | SYNGAP1 KIAA1938 | MRDLNSSIDLQSFMARGLNssMDMARLPSPTKEKPPPPPPG |
| Q96PV0 | T1077 | SIGNOR|iPTMNet | SYNGAP1 KIAA1938 | SGGGGGGQPPPLQRGKsQQLtVSAAQKPRPSSGNLLQSPEP |
| Q96ST3 | S158 | Sugiyama | SIN3A | GSQPQVYNDFLDIMKEFKSQsIDtPGVISRVSQLFKGHPDL |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99618 | S94 | Sugiyama | CDCA3 C8 GRCC8 TOME1 | ARtPMKTSsGDPPsPLVKQLsEVFETEDSKSNLPPEPVLPP |
| Q99755 | S486 | Sugiyama | PIP5K1A | GssFSRRAGssGNsCItyQPsVsGEHKAQVTTKAEVEPGVH |
| Q99848 | T261 | Sugiyama | EBNA1BP2 EBP2 | RRYKNQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGL |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BTE6 | S174 | Sugiyama | AARSD1 | IEQSVNEKIRDRLPVNVRELsLDDPEVEQVsGRGLPDDHAG |
| Q9BVJ6 | S77 | Sugiyama | UTP14A SDCCAG16 | NRRKLAERSEASLKVSEFNVssEGsGEKLVLADLLEPVKTS |
| Q9BXL7 | S116 | EPSD|PSP | CARD11 CARMA1 | EFYYPELYKLVTGKEPTRRFsTIVVEEGHEGLTHFLMNEVI |
| Q9BXS6 | S198 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TAITtPNFKKLHEAHFKEMEsIDQYIERKKKHFEEHNSMNE |
| Q9BXS6 | S363 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TtEAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQS |
| Q9BXS6 | S365 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | EAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQSKE |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C2 | S221 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TyGtTTAPRDEDGstLFRGWsQEGPVKsPAECREEHsKtPE |
| Q9C0C2 | S437 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQGsQ |
| Q9C0C2 | S899 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | RDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGRys |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9GZZ9 | S45 | Sugiyama | UBA5 UBE1DC1 | LQVPRSGDGGGGRVRIEKMssEVVDSNPysRLMALKRMGIV |
| Q9H1E3 | S113 | Sugiyama | NUCKS1 NUCKS JC7 | RQAASKAASKQREMLMEDVGsEEEQEEEDEAPFQEKDsGsD |
| Q9H254 | S2254 | PSP | SPTBN4 KIAA1642 SPTBN3 | QEsADRAEELPRRRRPERQEsVDQSEEAARRRRPERQESAE |
| Q9H6S3 | S693 | Sugiyama | EPS8L2 EPS8R2 PP13181 | EGVRVySQLTMQKAFLEKQQsGSELEELMNKFHSMNQRRGE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9NP61 | S366 | Sugiyama | ARFGAP3 ARFGAP1 | DDsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKD |
| Q9NQC7 | S362 | SIGNOR|PSP | CYLD CYLD1 KIAA0849 HSPC057 | STSDPGNRNRSELFYTLNGSsVDSQPQSKSKNTWYIDEVAE |
| Q9NQC7 | S418 | PSP | CYLD CYLD1 KIAA0849 HSPC057 | ssPPLQPPPVNSLTTENRFHsLPFsLtKMPNTNGsIGHsPL |
| Q9NQC7 | S772 | SIGNOR|PSP | CYLD CYLD1 KIAA0849 HSPC057 | LIIQMPRFGKDFKLFKKIFPsLELNITDLLEDTPRQCRICG |
| Q9NQW6 | S225 | Sugiyama | ANLN | LAATICsWEDDVNHsFAKQNsVQEQPGTACLSKFSSASGAs |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NSA2 | S555 | PSP | KCND1 | RRAKRRAIRLANSTASVSRGsMQELDMLAGLRRsHAPQSRS |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NSC5 | S120 | SIGNOR | HOMER3 | TQFAEKFQEVKEAARLAREKsQDGGELtsPALGLAsHQVPP |
| Q9NSC5 | S159 | SIGNOR | HOMER3 | PPsPLVSANGPGEEKLFRsQsADAPGPTERERLKKMLsEGS |
| Q9NSC5 | S176 | SIGNOR | HOMER3 | RsQsADAPGPTERERLKKMLsEGSVGEVQWEAEFFALQDSN |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NZV8 | S438 | ELM | KCND2 KIAA1044 | RADKRRAQKKARLARIRAAKsGSANAYMQSKRNGLLSNQLQ |
| Q9NZV8 | S459 | ELM | KCND2 KIAA1044 | GSANAYMQSKRNGLLSNQLQsSEDEQAFVSKSGSSFETQHH |
| Q9P0L9 | T591 | SIGNOR | PKD2L1 PKD2L PKDL TRPP3 | LAGQKDELQLsDLLKQGYNKtLLRLRLRKERVSDVQKVLQG |
| Q9UBS5 | S868 | SIGNOR | GABBR1 GPRC3A | TLVVLFVPKMRRLITRGEWQsEAQDtMKTGSstNNNEEEKS |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKV3 | S661 | Sugiyama | ACIN1 ACINUS KIAA0670 | SRSRSRSASSNSRKsLsPGVsRDsstsytEtKDPssGQEVA |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1537 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sGsEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERs |
| Q9UQ35 | S1653 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsR |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
| Q9UQ35 | T848 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KtPsRQsHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQ |
| Q9UQD0 | S541 | PSP | SCN8A MED | EDGMRRKAFRLPDNRIGRKFsIMNQSLLSIPGSPFLSRHNs |
| Q9UQD0 | S561 | SIGNOR|PSP | SCN8A MED | sIMNQSLLSIPGSPFLSRHNsKSSIFSFRGPGRFRDPGSEN |
| Q9UQD0 | S641 | SIGNOR|PSP | SCN8A MED | SQGSRSSRIFPSLRRSVKRNstVDCNGVVSLIGGPGSHIGG |
| Q9UQD0 | T642 | SIGNOR|PSP | SCN8A MED | QGSRSSRIFPSLRRSVKRNstVDCNGVVSLIGGPGSHIGGR |
| Q9UQL6 | S259 | EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9UQM7 | S25 | Sugiyama | CAMK2A CAMKA KIAA0968 | TCTRFTEEYQLFEELGKGAFsVVRRCVKVLAGQEYAAKIIN |
| Q9UQM7 | S314 | SIGNOR | CAMK2A CAMKA KIAA0968 | NARRKLKGAILttMLAtRNFsGGKSGGNKKSDGVKEssEst |
| Q9UQM7 | T261 | Sugiyama | CAMK2A CAMKA KIAA0968 | TPEAKDLINKMLtINPsKRItAAEALKHPWISHRStVAsCM |
| Q9UQM7 | T286 | SIGNOR|ELM|EPSD|PSP | CAMK2A CAMKA KIAA0968 | LKHPWISHRStVAsCMHRQEtVDCLKKFNARRKLKGAILtt |
| Q9UQM7 | T305 | SIGNOR|EPSD|PSP|Sugiyama | CAMK2A CAMKA KIAA0968 | EtVDCLKKFNARRKLKGAILttMLAtRNFsGGKSGGNKKSD |
| Q9UQM7 | T306 | SIGNOR|EPSD|PSP|Sugiyama | CAMK2A CAMKA KIAA0968 | tVDCLKKFNARRKLKGAILttMLAtRNFsGGKSGGNKKSDG |
| Q9Y281 | S24 | ELM | CFL2 | GVtVNDEVIKVFNDMKVRKsstQEEIKKRKKAVLFCLSDDK |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S178 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NVKDKLCSKRtDLCDHALHIsHDEL________________ |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2X7 | S592 | Sugiyama | GIT1 | PLLsCsQEGsRHtsKLsRHGsGADsDyENtQSGDPLLGLEG |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y496 | S687 | EPSD|PSP | KIF3A KIF3 | LERPRtSKGKARPKTGRRKRsAKPEtVIDSLLQ________ |
| Q9Y4D2 | S782 | SIGNOR|EPSD|PSP | DAGLA C11orf11 KIAA0659 NSDDR | TQERLAAELQARRAPLATMEsLSDTESLYSFDSRRSsGFRS |
| Q9Y4D2 | S808 | SIGNOR|EPSD|PSP | DAGLA C11orf11 KIAA0659 NSDDR | SLYSFDSRRSsGFRSIRGsPsLHAVLERDEGHLFYIDPAIP |
| Q9Y4P3 | T433 | Sugiyama | TBL2 WBSCR13 UNQ563/PRO1125 | QGHLKRASNESTRQRLQQQLtQAQETLKSLGALKK______ |
| Q9Y4W2 | S641 | Sugiyama | LAS1L MSTP060 | ENARLLAQKRGALQGsAWQVssEDVRWDTFPLGRMPGQTED |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y618 | S2426 | SIGNOR|PSP | NCOR2 CTG26 | PsSRKAKsPAPGLASGDRPPsVSSVHSEGDCNRRTPLTNRV |
| Q9Y618 | S2453 | PSP | NCOR2 CTG26 | EGDCNRRTPLTNRVWEDRPSsAGSTPFPYNPLIMRLQAGVM |
| Q9Y6K9 | S196 | Sugiyama | IKBKG FIP3 NEMO | AASEQARQLESEREALQQQHsVQVDQLRMQGQSVEAALRME |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.221479e-08 | 7.913 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.818097e-08 | 7.008 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.355963e-07 | 6.271 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.143341e-06 | 5.942 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.466455e-06 | 5.834 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.329720e-06 | 5.633 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.244286e-06 | 5.489 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.839737e-06 | 5.315 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.952948e-06 | 5.158 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.521582e-06 | 5.069 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.292517e-06 | 5.032 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.013282e-05 | 4.696 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.785766e-05 | 4.422 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.347893e-05 | 4.362 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.898475e-05 | 4.310 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.462570e-05 | 4.263 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.675803e-05 | 4.175 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.495854e-05 | 4.187 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.087633e-05 | 4.216 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.294185e-05 | 4.201 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.631601e-05 | 4.117 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.241743e-04 | 3.906 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.135985e-04 | 3.670 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.115500e-04 | 3.675 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.270603e-04 | 3.644 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.257219e-04 | 3.646 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.479910e-04 | 3.606 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.515802e-04 | 3.599 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.555997e-04 | 3.592 | 1 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.900742e-04 | 3.537 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.900742e-04 | 3.537 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.247182e-04 | 3.488 | 1 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.561499e-04 | 3.448 | 1 | 1 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.412422e-04 | 3.467 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.575551e-04 | 3.447 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.810266e-04 | 3.419 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.828740e-04 | 3.417 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.797496e-04 | 3.421 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.157079e-04 | 3.381 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.568619e-04 | 3.340 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.159274e-04 | 3.287 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.430405e-04 | 3.265 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.791111e-04 | 3.237 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.112346e-04 | 3.214 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.381762e-04 | 3.195 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.641130e-04 | 3.178 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.732381e-04 | 3.172 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.853893e-04 | 3.164 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.160107e-04 | 3.145 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.556327e-04 | 3.122 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.660591e-04 | 3.116 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.799947e-04 | 3.108 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.244537e-04 | 3.084 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.983703e-04 | 3.047 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.015938e-03 | 2.993 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.820681e-04 | 3.008 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.820681e-04 | 3.008 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.820681e-04 | 3.008 | 1 | 1 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.015938e-03 | 2.993 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.820681e-04 | 3.008 | 1 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.677434e-04 | 3.014 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.062689e-03 | 2.974 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.110039e-03 | 2.955 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.118947e-03 | 2.951 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.201272e-03 | 2.920 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.201272e-03 | 2.920 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.559438e-03 | 2.807 | 1 | 1 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.759196e-03 | 2.755 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.759196e-03 | 2.755 | 1 | 1 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.759196e-03 | 2.755 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.854530e-03 | 2.732 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.178086e-03 | 2.662 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.288054e-03 | 2.641 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.270678e-03 | 2.644 | 1 | 0 |
| Meiosis | R-HSA-1500620 | 2.270678e-03 | 2.644 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.179847e-03 | 2.662 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.279289e-03 | 2.642 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.144199e-03 | 2.669 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.314336e-03 | 2.636 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.362574e-03 | 2.627 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.959292e-03 | 2.529 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.857826e-03 | 2.544 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.854489e-03 | 2.544 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.857826e-03 | 2.544 | 1 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.964991e-03 | 2.528 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.811122e-03 | 2.551 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.285260e-03 | 2.483 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.414362e-03 | 2.467 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.480977e-03 | 2.458 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.692508e-03 | 2.433 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.709534e-03 | 2.431 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.963608e-03 | 2.402 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.771325e-03 | 2.424 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.772064e-03 | 2.423 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.084814e-03 | 2.389 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.555028e-03 | 2.342 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.620227e-03 | 2.335 | 1 | 1 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.726401e-03 | 2.325 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.014163e-03 | 2.300 | 1 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.232898e-03 | 2.281 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.546684e-03 | 2.256 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.546684e-03 | 2.256 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.715900e-03 | 2.243 | 1 | 1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.981896e-03 | 2.223 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.981896e-03 | 2.223 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.638730e-03 | 2.249 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.814951e-03 | 2.235 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.559028e-03 | 2.255 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.052983e-03 | 2.218 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.229290e-03 | 2.206 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.373338e-03 | 2.196 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.425354e-03 | 2.192 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.383889e-03 | 2.132 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.018710e-03 | 2.154 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.454138e-03 | 2.128 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.454138e-03 | 2.128 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.339758e-03 | 2.134 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.018710e-03 | 2.154 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.620052e-03 | 2.118 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.035369e-03 | 2.095 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.143530e-03 | 2.089 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.421277e-03 | 2.075 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.403636e-03 | 2.027 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.421508e-03 | 2.026 | 1 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.028818e-02 | 1.988 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.028818e-02 | 1.988 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.831600e-03 | 2.007 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.028346e-02 | 1.988 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.567241e-03 | 2.019 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.567241e-03 | 2.019 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.030685e-02 | 1.987 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.041902e-02 | 1.982 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.077708e-02 | 1.967 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.078132e-02 | 1.967 | 1 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.080927e-02 | 1.966 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.080927e-02 | 1.966 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.080927e-02 | 1.966 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.091585e-02 | 1.962 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.131470e-02 | 1.946 | 1 | 1 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.113489e-02 | 1.953 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.201778e-02 | 1.920 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.113915e-02 | 1.953 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.122978e-02 | 1.950 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.131470e-02 | 1.946 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.131470e-02 | 1.946 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.229123e-02 | 1.910 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.252841e-02 | 1.902 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.284884e-02 | 1.891 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.365242e-02 | 1.865 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.398599e-02 | 1.854 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.443819e-02 | 1.840 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.459136e-02 | 1.836 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.518567e-02 | 1.819 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.561062e-02 | 1.807 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.601254e-02 | 1.796 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.685760e-02 | 1.773 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.719220e-02 | 1.765 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.608472e-02 | 1.794 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.624953e-02 | 1.789 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.683532e-02 | 1.774 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.786904e-02 | 1.748 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.786904e-02 | 1.748 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.719220e-02 | 1.765 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.885816e-02 | 1.725 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.958713e-02 | 1.708 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.012018e-02 | 1.696 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.061056e-02 | 1.686 | 1 | 1 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.073753e-02 | 1.683 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.244394e-02 | 1.649 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.341060e-02 | 1.631 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.156772e-02 | 1.666 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.339648e-02 | 1.631 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.341060e-02 | 1.631 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.082458e-02 | 1.681 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.392187e-02 | 1.621 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.392187e-02 | 1.621 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.402512e-02 | 1.619 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.407385e-02 | 1.618 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.472853e-02 | 1.607 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.632435e-02 | 1.580 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.716511e-02 | 1.566 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.722165e-02 | 1.565 | 1 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.734163e-02 | 1.563 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.734163e-02 | 1.563 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.174969e-02 | 1.498 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.174969e-02 | 1.498 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.174969e-02 | 1.498 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.174969e-02 | 1.498 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.174969e-02 | 1.498 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.005046e-02 | 1.522 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.245354e-02 | 1.489 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.245354e-02 | 1.489 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.109997e-02 | 1.507 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.258276e-02 | 1.487 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.364891e-02 | 1.473 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.141356e-02 | 1.503 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.109997e-02 | 1.507 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.452271e-02 | 1.462 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.491258e-02 | 1.457 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.491258e-02 | 1.457 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.521215e-02 | 1.453 | 1 | 1 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.523985e-02 | 1.453 | 1 | 1 |
| Membrane Trafficking | R-HSA-199991 | 3.527911e-02 | 1.452 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.551305e-02 | 1.450 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.551305e-02 | 1.450 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 3.551305e-02 | 1.450 | 1 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.559307e-02 | 1.449 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.559307e-02 | 1.449 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.559307e-02 | 1.449 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.565795e-02 | 1.448 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.577137e-02 | 1.446 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.650214e-02 | 1.438 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.757696e-02 | 1.425 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.357894e-02 | 1.361 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.389741e-02 | 1.358 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.389741e-02 | 1.358 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.389741e-02 | 1.358 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.389741e-02 | 1.358 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.389741e-02 | 1.358 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.138991e-02 | 1.383 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.975501e-02 | 1.401 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.157873e-02 | 1.381 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.982191e-02 | 1.400 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.169560e-02 | 1.380 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.969234e-02 | 1.401 | 1 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.037429e-02 | 1.394 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.381337e-02 | 1.358 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.998206e-02 | 1.398 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.801634e-02 | 1.420 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.357894e-02 | 1.361 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.037429e-02 | 1.394 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.969234e-02 | 1.401 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.969234e-02 | 1.401 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.455359e-02 | 1.351 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.482316e-02 | 1.348 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.558870e-02 | 1.341 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.567291e-02 | 1.340 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.590550e-02 | 1.338 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.612514e-02 | 1.336 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.629108e-02 | 1.335 | 1 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.971538e-02 | 1.304 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.971538e-02 | 1.304 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.980762e-02 | 1.303 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.190182e-02 | 1.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.245772e-02 | 1.280 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.546477e-02 | 1.256 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.641044e-02 | 1.249 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.829424e-02 | 1.234 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.862759e-02 | 1.232 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.862759e-02 | 1.232 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.864076e-02 | 1.232 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.899772e-02 | 1.229 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.899772e-02 | 1.229 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.899772e-02 | 1.229 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.118587e-02 | 1.148 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.118587e-02 | 1.148 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 7.118587e-02 | 1.148 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.104594e-02 | 1.148 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.104594e-02 | 1.148 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.984681e-02 | 1.156 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.984681e-02 | 1.156 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.060226e-02 | 1.218 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.452972e-02 | 1.190 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.216883e-02 | 1.206 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.511016e-02 | 1.186 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.983891e-02 | 1.156 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.104594e-02 | 1.148 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.469979e-02 | 1.189 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.703213e-02 | 1.174 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.431467e-02 | 1.192 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.924514e-02 | 1.160 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.060226e-02 | 1.218 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.118587e-02 | 1.148 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.118587e-02 | 1.148 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.043603e-02 | 1.152 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.680124e-02 | 1.175 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.153387e-02 | 1.211 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.603115e-02 | 1.180 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.286715e-02 | 1.137 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.418119e-02 | 1.130 | 1 | 1 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.629671e-02 | 1.117 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.843865e-02 | 1.105 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.927944e-02 | 1.101 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.976621e-02 | 1.098 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.976621e-02 | 1.098 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.976621e-02 | 1.098 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.020053e-02 | 1.096 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.260994e-02 | 1.083 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.277358e-02 | 1.082 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.277358e-02 | 1.082 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.414551e-02 | 1.075 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.604104e-02 | 1.065 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.700473e-02 | 1.060 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.713518e-02 | 1.060 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 8.742101e-02 | 1.058 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 8.742101e-02 | 1.058 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 8.742101e-02 | 1.058 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 8.742101e-02 | 1.058 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.922289e-02 | 1.050 | 1 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.119056e-01 | 0.951 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.119056e-01 | 0.951 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.119056e-01 | 0.951 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.119056e-01 | 0.951 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.119056e-01 | 0.951 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.119056e-01 | 0.951 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.119056e-01 | 0.951 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 9.318582e-02 | 1.031 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.318582e-02 | 1.031 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.318582e-02 | 1.031 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.054427e-01 | 0.977 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.244659e-02 | 1.034 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.244659e-02 | 1.034 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.244659e-02 | 1.034 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.076441e-01 | 0.968 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.076441e-01 | 0.968 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.076441e-01 | 0.968 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.045898e-02 | 1.044 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.019159e-01 | 0.992 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.084044e-01 | 0.965 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.727243e-02 | 1.012 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.063793e-01 | 0.973 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.244566e-02 | 1.034 | 1 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.079777e-01 | 0.967 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.194957e-02 | 1.036 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.358052e-02 | 1.029 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.057135e-01 | 0.976 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.115306e-01 | 0.953 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.054427e-01 | 0.977 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.054427e-01 | 0.977 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.636533e-02 | 1.016 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 9.389949e-02 | 1.027 | 1 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.076441e-01 | 0.968 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.585813e-02 | 1.018 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.194957e-02 | 1.036 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.985177e-02 | 1.001 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.141218e-01 | 0.943 | 1 | 1 |
| G-protein mediated events | R-HSA-112040 | 1.165989e-01 | 0.933 | 1 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.175948e-01 | 0.930 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.175948e-01 | 0.930 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.175948e-01 | 0.930 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.175948e-01 | 0.930 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.175948e-01 | 0.930 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.175948e-01 | 0.930 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.185177e-01 | 0.926 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.194492e-01 | 0.923 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.194492e-01 | 0.923 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.197016e-01 | 0.922 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.197016e-01 | 0.922 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.197016e-01 | 0.922 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.197016e-01 | 0.922 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.197113e-01 | 0.922 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.197113e-01 | 0.922 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.249951e-01 | 0.903 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.249951e-01 | 0.903 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.254289e-01 | 0.902 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.255414e-01 | 0.901 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.302804e-01 | 0.885 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.314625e-01 | 0.881 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.339385e-01 | 0.873 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.350959e-01 | 0.869 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.599825e-01 | 0.796 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.599825e-01 | 0.796 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.599825e-01 | 0.796 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.599825e-01 | 0.796 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.440801e-01 | 0.841 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.440801e-01 | 0.841 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.440801e-01 | 0.841 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.722993e-01 | 0.764 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.722993e-01 | 0.764 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.722993e-01 | 0.764 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.459445e-01 | 0.836 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.459445e-01 | 0.836 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.681443e-01 | 0.774 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.681443e-01 | 0.774 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.413748e-01 | 0.850 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.597650e-01 | 0.797 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.790623e-01 | 0.747 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.790623e-01 | 0.747 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.855039e-01 | 0.732 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.550049e-01 | 0.810 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.413748e-01 | 0.850 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.597650e-01 | 0.797 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.550049e-01 | 0.810 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.722993e-01 | 0.764 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.413748e-01 | 0.850 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.837526e-01 | 0.736 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.667249e-01 | 0.778 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.722993e-01 | 0.764 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.574727e-01 | 0.803 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.508770e-01 | 0.821 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.869824e-01 | 0.728 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.597650e-01 | 0.797 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.599825e-01 | 0.796 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.599825e-01 | 0.796 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.599825e-01 | 0.796 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.440801e-01 | 0.841 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.855039e-01 | 0.732 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.502633e-01 | 0.823 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.709693e-01 | 0.767 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.460638e-01 | 0.835 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.460638e-01 | 0.835 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.406942e-01 | 0.852 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.406942e-01 | 0.852 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.855039e-01 | 0.732 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.724183e-01 | 0.763 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.456658e-01 | 0.837 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.554724e-01 | 0.808 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.839058e-01 | 0.735 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.478476e-01 | 0.830 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.578903e-01 | 0.802 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.527888e-01 | 0.816 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.855039e-01 | 0.732 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.502633e-01 | 0.823 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.502633e-01 | 0.823 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.667249e-01 | 0.778 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.440801e-01 | 0.841 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.440801e-01 | 0.841 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.722993e-01 | 0.764 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.578903e-01 | 0.802 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.837526e-01 | 0.736 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.855039e-01 | 0.732 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.440688e-01 | 0.841 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.790623e-01 | 0.747 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.457861e-01 | 0.836 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.459445e-01 | 0.836 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.597531e-01 | 0.797 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.792819e-01 | 0.746 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.818302e-01 | 0.740 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.667249e-01 | 0.778 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.722993e-01 | 0.764 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.722993e-01 | 0.764 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.896281e-01 | 0.722 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.914393e-01 | 0.718 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.914393e-01 | 0.718 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.914393e-01 | 0.718 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.914393e-01 | 0.718 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.914393e-01 | 0.718 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.914393e-01 | 0.718 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.939241e-01 | 0.712 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.939241e-01 | 0.712 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.941906e-01 | 0.712 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.951174e-01 | 0.710 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.973462e-01 | 0.705 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.973462e-01 | 0.705 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.984002e-01 | 0.702 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.112941e-01 | 0.675 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.112941e-01 | 0.675 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.112941e-01 | 0.675 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.112941e-01 | 0.675 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.112941e-01 | 0.675 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.112941e-01 | 0.675 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 2.995651e-01 | 0.524 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.995651e-01 | 0.524 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.995651e-01 | 0.524 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.995651e-01 | 0.524 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.995651e-01 | 0.524 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.995651e-01 | 0.524 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.995651e-01 | 0.524 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.995651e-01 | 0.524 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.022752e-01 | 0.694 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.022752e-01 | 0.694 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.022752e-01 | 0.694 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.022752e-01 | 0.694 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.022752e-01 | 0.694 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.022752e-01 | 0.694 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.022752e-01 | 0.694 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.456256e-01 | 0.610 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.456256e-01 | 0.610 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.456256e-01 | 0.610 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.456256e-01 | 0.610 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.456256e-01 | 0.610 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.779614e-01 | 0.423 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.779614e-01 | 0.423 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.779614e-01 | 0.423 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.779614e-01 | 0.423 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.779614e-01 | 0.423 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.779614e-01 | 0.423 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.779614e-01 | 0.423 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.779614e-01 | 0.423 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.779614e-01 | 0.423 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.779614e-01 | 0.423 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.779614e-01 | 0.423 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.779614e-01 | 0.423 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.779614e-01 | 0.423 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.019128e-01 | 0.695 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.019128e-01 | 0.695 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 2.892680e-01 | 0.539 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 2.892680e-01 | 0.539 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.325928e-01 | 0.633 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.325928e-01 | 0.633 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.156699e-01 | 0.666 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.156699e-01 | 0.666 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.156699e-01 | 0.666 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.325943e-01 | 0.478 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.325943e-01 | 0.478 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.325943e-01 | 0.478 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.325943e-01 | 0.478 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.325943e-01 | 0.478 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.325943e-01 | 0.478 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.475873e-01 | 0.349 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.991767e-01 | 0.701 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.406752e-01 | 0.619 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.406752e-01 | 0.619 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.959358e-01 | 0.529 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.959358e-01 | 0.529 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.959358e-01 | 0.529 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.959358e-01 | 0.529 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.959358e-01 | 0.529 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.017472e-01 | 0.695 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.017472e-01 | 0.695 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.662959e-01 | 0.575 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.662959e-01 | 0.575 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.751289e-01 | 0.426 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.751289e-01 | 0.426 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.201869e-01 | 0.657 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.201869e-01 | 0.657 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.280492e-01 | 0.484 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.280492e-01 | 0.484 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.923772e-01 | 0.534 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.858914e-01 | 0.544 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.601338e-01 | 0.444 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.165067e-01 | 0.380 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.165067e-01 | 0.380 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.165067e-01 | 0.380 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.094234e-01 | 0.293 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.094234e-01 | 0.293 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 5.094234e-01 | 0.293 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 5.094234e-01 | 0.293 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.094234e-01 | 0.293 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.094234e-01 | 0.293 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.094234e-01 | 0.293 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.528426e-01 | 0.597 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.528426e-01 | 0.597 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.086469e-01 | 0.511 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.453332e-01 | 0.462 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.453332e-01 | 0.462 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.919803e-01 | 0.407 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.919803e-01 | 0.407 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.919803e-01 | 0.407 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.919803e-01 | 0.407 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.101217e-01 | 0.678 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.564537e-01 | 0.341 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.564537e-01 | 0.341 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.564537e-01 | 0.341 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.074106e-01 | 0.512 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.469580e-01 | 0.607 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.396779e-01 | 0.469 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.396779e-01 | 0.469 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.261081e-01 | 0.487 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.261081e-01 | 0.487 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.261081e-01 | 0.487 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.984500e-01 | 0.400 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.779882e-01 | 0.423 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.779882e-01 | 0.423 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.779882e-01 | 0.423 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.067979e-01 | 0.513 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.011699e-01 | 0.397 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.247682e-01 | 0.372 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.947721e-01 | 0.306 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.643410e-01 | 0.248 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.643410e-01 | 0.248 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.643410e-01 | 0.248 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.643410e-01 | 0.248 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.099048e-01 | 0.678 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.838367e-01 | 0.416 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.843873e-01 | 0.315 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.201279e-01 | 0.495 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.313260e-01 | 0.275 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.172153e-01 | 0.380 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.369302e-01 | 0.360 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.136987e-01 | 0.289 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.136987e-01 | 0.289 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.015668e-01 | 0.300 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.535007e-01 | 0.343 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.632174e-01 | 0.334 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.894187e-01 | 0.310 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.261768e-01 | 0.279 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.420966e-01 | 0.266 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.420966e-01 | 0.266 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.420966e-01 | 0.266 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.660303e-01 | 0.247 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.660303e-01 | 0.247 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.660303e-01 | 0.247 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.660303e-01 | 0.247 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.660303e-01 | 0.247 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.660303e-01 | 0.247 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.243725e-01 | 0.280 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.501818e-01 | 0.259 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.695096e-01 | 0.244 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.958835e-01 | 0.225 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.958835e-01 | 0.225 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.856096e-01 | 0.232 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.432249e-01 | 0.265 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.528426e-01 | 0.597 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.958835e-01 | 0.225 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.958835e-01 | 0.225 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.246081e-01 | 0.489 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.620223e-01 | 0.335 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.620223e-01 | 0.335 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.843873e-01 | 0.315 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.843873e-01 | 0.315 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.436129e-01 | 0.353 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.698307e-01 | 0.328 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.586000e-01 | 0.587 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.028484e-01 | 0.693 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.987320e-01 | 0.399 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.662959e-01 | 0.575 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.861609e-01 | 0.232 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.234058e-01 | 0.373 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.987320e-01 | 0.399 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.987320e-01 | 0.399 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.482477e-01 | 0.605 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.719341e-01 | 0.430 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.011699e-01 | 0.397 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.242517e-01 | 0.372 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.156699e-01 | 0.666 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.449763e-01 | 0.462 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.542527e-01 | 0.343 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.242517e-01 | 0.372 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.787837e-01 | 0.555 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.313260e-01 | 0.275 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.856096e-01 | 0.232 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.894108e-01 | 0.230 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.923772e-01 | 0.534 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.775385e-01 | 0.321 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.528426e-01 | 0.597 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.564537e-01 | 0.341 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.936895e-01 | 0.405 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.353293e-01 | 0.628 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.414777e-01 | 0.617 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.488780e-01 | 0.261 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.629577e-01 | 0.250 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.165067e-01 | 0.380 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.564537e-01 | 0.341 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.234058e-01 | 0.373 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.082338e-01 | 0.681 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.247682e-01 | 0.372 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.947721e-01 | 0.306 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.313260e-01 | 0.275 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.358172e-01 | 0.271 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.469580e-01 | 0.607 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.229198e-01 | 0.374 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.569718e-01 | 0.254 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.803000e-01 | 0.318 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.727444e-01 | 0.564 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.281246e-01 | 0.642 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.640295e-01 | 0.578 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.751289e-01 | 0.426 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.923772e-01 | 0.534 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.165067e-01 | 0.380 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.165067e-01 | 0.380 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.094234e-01 | 0.293 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.215818e-01 | 0.654 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.643410e-01 | 0.248 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.015456e-01 | 0.396 | 1 | 1 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.660303e-01 | 0.247 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.735301e-01 | 0.241 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.776368e-01 | 0.238 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.776368e-01 | 0.238 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.894108e-01 | 0.230 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.072790e-01 | 0.512 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.072790e-01 | 0.512 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.074106e-01 | 0.512 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.720436e-01 | 0.326 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.723912e-01 | 0.326 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.196142e-01 | 0.495 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.858271e-01 | 0.232 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.710627e-01 | 0.567 | 1 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.569718e-01 | 0.254 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.858271e-01 | 0.232 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.513279e-01 | 0.454 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.045737e-01 | 0.297 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.456256e-01 | 0.610 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.406752e-01 | 0.619 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.280492e-01 | 0.484 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.234058e-01 | 0.373 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.234058e-01 | 0.373 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.643410e-01 | 0.248 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.643410e-01 | 0.248 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.643410e-01 | 0.248 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.643410e-01 | 0.248 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.830288e-01 | 0.417 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.843873e-01 | 0.315 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.844862e-01 | 0.315 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.660303e-01 | 0.247 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.120208e-01 | 0.291 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.292541e-01 | 0.640 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.816697e-01 | 0.317 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.923772e-01 | 0.534 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.412055e-01 | 0.618 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.148348e-01 | 0.288 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.498705e-01 | 0.602 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.414777e-01 | 0.617 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.601338e-01 | 0.444 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.270735e-01 | 0.278 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.848962e-01 | 0.545 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.325943e-01 | 0.478 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.843873e-01 | 0.315 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.684889e-01 | 0.434 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.261768e-01 | 0.279 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.706866e-01 | 0.244 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.545556e-01 | 0.594 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.387912e-01 | 0.622 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.773614e-01 | 0.557 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 4.117591e-01 | 0.385 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.022752e-01 | 0.694 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.751289e-01 | 0.426 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.449763e-01 | 0.462 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.229198e-01 | 0.374 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.670868e-01 | 0.435 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.958835e-01 | 0.225 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.657260e-01 | 0.576 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.698307e-01 | 0.328 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.526789e-01 | 0.453 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.923772e-01 | 0.534 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.727444e-01 | 0.564 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.695096e-01 | 0.244 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.935017e-01 | 0.227 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.200142e-01 | 0.658 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.832407e-01 | 0.234 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.733710e-01 | 0.242 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.307266e-01 | 0.637 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.281381e-01 | 0.484 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.221323e-01 | 0.653 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.079762e-01 | 0.294 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.980163e-01 | 0.303 | 1 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.995651e-01 | 0.524 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.995651e-01 | 0.524 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.779614e-01 | 0.423 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.779614e-01 | 0.423 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.475873e-01 | 0.349 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.475873e-01 | 0.349 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.017472e-01 | 0.695 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.751289e-01 | 0.426 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.280492e-01 | 0.484 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.187700e-01 | 0.497 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.601338e-01 | 0.444 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.094234e-01 | 0.293 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.094234e-01 | 0.293 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.919803e-01 | 0.407 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.919803e-01 | 0.407 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.011699e-01 | 0.397 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.643410e-01 | 0.248 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.643410e-01 | 0.248 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.136987e-01 | 0.289 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.136987e-01 | 0.289 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.142116e-01 | 0.289 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.483775e-01 | 0.261 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.372506e-01 | 0.472 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.372506e-01 | 0.472 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.681679e-01 | 0.434 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.605315e-01 | 0.584 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.151227e-01 | 0.667 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.775385e-01 | 0.321 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.764130e-01 | 0.322 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.843873e-01 | 0.315 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.151227e-01 | 0.667 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.892680e-01 | 0.539 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.719341e-01 | 0.430 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.564537e-01 | 0.341 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.542527e-01 | 0.343 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.881803e-01 | 0.311 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.187700e-01 | 0.497 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.723912e-01 | 0.326 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.507864e-01 | 0.346 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.015668e-01 | 0.300 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.894187e-01 | 0.310 | 1 | 1 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.986102e-01 | 0.525 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.325943e-01 | 0.478 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.325943e-01 | 0.478 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.959358e-01 | 0.529 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.643410e-01 | 0.248 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.313260e-01 | 0.275 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.537602e-01 | 0.451 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.197816e-01 | 0.658 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.816801e-01 | 0.235 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.557718e-01 | 0.592 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.166191e-01 | 0.664 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.066846e-01 | 0.685 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.220833e-01 | 0.375 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.021185e-01 | 0.396 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.021236e-01 | 0.396 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.414777e-01 | 0.617 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.964600e-01 | 0.304 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.200142e-01 | 0.658 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.414777e-01 | 0.617 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.006166e-01 | 0.397 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.298506e-01 | 0.276 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.995651e-01 | 0.524 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.995651e-01 | 0.524 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.779614e-01 | 0.423 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.475873e-01 | 0.349 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.094234e-01 | 0.293 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.094234e-01 | 0.293 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.190452e-01 | 0.496 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.547845e-01 | 0.450 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.947721e-01 | 0.306 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.947721e-01 | 0.306 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.643410e-01 | 0.248 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.643410e-01 | 0.248 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.921994e-01 | 0.308 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.894187e-01 | 0.310 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.958835e-01 | 0.225 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.051249e-01 | 0.688 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.547845e-01 | 0.450 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.441901e-01 | 0.612 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.404621e-01 | 0.468 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.601338e-01 | 0.444 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.759623e-01 | 0.425 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.892680e-01 | 0.539 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.892680e-01 | 0.539 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.621799e-01 | 0.581 | 1 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.843873e-01 | 0.315 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.105413e-01 | 0.508 | 1 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.737411e-01 | 0.563 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.844862e-01 | 0.315 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.456256e-01 | 0.610 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.456256e-01 | 0.610 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.779614e-01 | 0.423 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.892680e-01 | 0.539 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.475873e-01 | 0.349 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.751289e-01 | 0.426 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.165067e-01 | 0.380 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.094234e-01 | 0.293 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.074106e-01 | 0.512 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.643410e-01 | 0.248 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 5.695096e-01 | 0.244 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.755961e-01 | 0.240 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.267916e-01 | 0.644 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.923772e-01 | 0.534 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.502887e-01 | 0.347 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.683782e-01 | 0.245 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.030203e-01 | 0.298 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 3.601338e-01 | 0.444 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.190452e-01 | 0.496 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.203404e-01 | 0.657 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.142116e-01 | 0.289 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.601338e-01 | 0.444 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.165067e-01 | 0.380 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.984500e-01 | 0.400 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.865413e-01 | 0.232 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.923772e-01 | 0.534 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.187700e-01 | 0.497 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.660303e-01 | 0.247 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.247682e-01 | 0.372 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.682066e-01 | 0.434 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.165067e-01 | 0.380 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.342515e-01 | 0.630 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.643410e-01 | 0.248 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.958835e-01 | 0.225 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.564537e-01 | 0.341 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.858939e-01 | 0.313 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.384508e-01 | 0.269 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.660303e-01 | 0.247 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.961789e-01 | 0.225 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.961789e-01 | 0.225 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.961789e-01 | 0.225 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.961789e-01 | 0.225 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.966320e-01 | 0.224 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.988410e-01 | 0.223 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.988410e-01 | 0.223 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.988410e-01 | 0.223 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.988410e-01 | 0.223 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.988410e-01 | 0.223 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.988410e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.988410e-01 | 0.223 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.999856e-01 | 0.222 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.999856e-01 | 0.222 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.999856e-01 | 0.222 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.024945e-01 | 0.220 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.051536e-01 | 0.218 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.117891e-01 | 0.213 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.131136e-01 | 0.212 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.131136e-01 | 0.212 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.131136e-01 | 0.212 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.131136e-01 | 0.212 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.131136e-01 | 0.212 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.131136e-01 | 0.212 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.131136e-01 | 0.212 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.131136e-01 | 0.212 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 6.131136e-01 | 0.212 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.131136e-01 | 0.212 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.131136e-01 | 0.212 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.131136e-01 | 0.212 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.131136e-01 | 0.212 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.131136e-01 | 0.212 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.131136e-01 | 0.212 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.131136e-01 | 0.212 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.131136e-01 | 0.212 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.131136e-01 | 0.212 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.133854e-01 | 0.212 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.178509e-01 | 0.209 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.178509e-01 | 0.209 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.180934e-01 | 0.209 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.180934e-01 | 0.209 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.180934e-01 | 0.209 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.180934e-01 | 0.209 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.190133e-01 | 0.208 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.211797e-01 | 0.207 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.297471e-01 | 0.201 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.297471e-01 | 0.201 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.297471e-01 | 0.201 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.297471e-01 | 0.201 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.297471e-01 | 0.201 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.307997e-01 | 0.200 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.307997e-01 | 0.200 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.351491e-01 | 0.197 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.352559e-01 | 0.197 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.363839e-01 | 0.196 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.409225e-01 | 0.193 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.409225e-01 | 0.193 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.409225e-01 | 0.193 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.453727e-01 | 0.190 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.453727e-01 | 0.190 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.453727e-01 | 0.190 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.453727e-01 | 0.190 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.453727e-01 | 0.190 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.511259e-01 | 0.186 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.548052e-01 | 0.184 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.555474e-01 | 0.183 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.564286e-01 | 0.183 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.564286e-01 | 0.183 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.564286e-01 | 0.183 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.564286e-01 | 0.183 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.564286e-01 | 0.183 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.564286e-01 | 0.183 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.564286e-01 | 0.183 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 6.564286e-01 | 0.183 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.564286e-01 | 0.183 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.564286e-01 | 0.183 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.564286e-01 | 0.183 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.564286e-01 | 0.183 | 0 | 0 |
| Agmatine biosynthesis | R-HSA-351143 | 6.564286e-01 | 0.183 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.564286e-01 | 0.183 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.564286e-01 | 0.183 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.564286e-01 | 0.183 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.564286e-01 | 0.183 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.564286e-01 | 0.183 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.587638e-01 | 0.181 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.587638e-01 | 0.181 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.587638e-01 | 0.181 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.587638e-01 | 0.181 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.587638e-01 | 0.181 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.587638e-01 | 0.181 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.587638e-01 | 0.181 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.587638e-01 | 0.181 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.642145e-01 | 0.178 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.643396e-01 | 0.178 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.643396e-01 | 0.178 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.648734e-01 | 0.177 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.656226e-01 | 0.177 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.684495e-01 | 0.175 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.684495e-01 | 0.175 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.684495e-01 | 0.175 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.684495e-01 | 0.175 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.684495e-01 | 0.175 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.684495e-01 | 0.175 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.684495e-01 | 0.175 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.686212e-01 | 0.175 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.726178e-01 | 0.172 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.768146e-01 | 0.170 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.788363e-01 | 0.168 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.791994e-01 | 0.168 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.791994e-01 | 0.168 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.791994e-01 | 0.168 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.859268e-01 | 0.164 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.859268e-01 | 0.164 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.859268e-01 | 0.164 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.859268e-01 | 0.164 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.859268e-01 | 0.164 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.859268e-01 | 0.164 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.859268e-01 | 0.164 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.859268e-01 | 0.164 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.898115e-01 | 0.161 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.898115e-01 | 0.161 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.904071e-01 | 0.161 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 6.904071e-01 | 0.161 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.905210e-01 | 0.161 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.948964e-01 | 0.158 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.948964e-01 | 0.158 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.948964e-01 | 0.158 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.948964e-01 | 0.158 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.948964e-01 | 0.158 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.948964e-01 | 0.158 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.948964e-01 | 0.158 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.948964e-01 | 0.158 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.948964e-01 | 0.158 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.948964e-01 | 0.158 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.948964e-01 | 0.158 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.948964e-01 | 0.158 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.948964e-01 | 0.158 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.948964e-01 | 0.158 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.948964e-01 | 0.158 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.948964e-01 | 0.158 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.948964e-01 | 0.158 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.948964e-01 | 0.158 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.979776e-01 | 0.156 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.058848e-01 | 0.151 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.058848e-01 | 0.151 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.063792e-01 | 0.151 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.063792e-01 | 0.151 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.087692e-01 | 0.149 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.090705e-01 | 0.149 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.090705e-01 | 0.149 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.112517e-01 | 0.148 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.112517e-01 | 0.148 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.112517e-01 | 0.148 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.112873e-01 | 0.148 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.112873e-01 | 0.148 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.112873e-01 | 0.148 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.112873e-01 | 0.148 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.112873e-01 | 0.148 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.112873e-01 | 0.148 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.125355e-01 | 0.147 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.148932e-01 | 0.146 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.148932e-01 | 0.146 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.148932e-01 | 0.146 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.159528e-01 | 0.145 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.159528e-01 | 0.145 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.159528e-01 | 0.145 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.159528e-01 | 0.145 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.159528e-01 | 0.145 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.172975e-01 | 0.144 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.193690e-01 | 0.143 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.225210e-01 | 0.141 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.226520e-01 | 0.141 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 7.261683e-01 | 0.139 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.266786e-01 | 0.139 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.290592e-01 | 0.137 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.290592e-01 | 0.137 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.290592e-01 | 0.137 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.290592e-01 | 0.137 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.290592e-01 | 0.137 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.290592e-01 | 0.137 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.290592e-01 | 0.137 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.290592e-01 | 0.137 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.290592e-01 | 0.137 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.290592e-01 | 0.137 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.290592e-01 | 0.137 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.290592e-01 | 0.137 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.290592e-01 | 0.137 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.290592e-01 | 0.137 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.290592e-01 | 0.137 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.309970e-01 | 0.136 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.309970e-01 | 0.136 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.309970e-01 | 0.136 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.309970e-01 | 0.136 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.357493e-01 | 0.133 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.376267e-01 | 0.132 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.413843e-01 | 0.130 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.428369e-01 | 0.129 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.488636e-01 | 0.126 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.491331e-01 | 0.125 | 1 | 1 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.493165e-01 | 0.125 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.495092e-01 | 0.125 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.496631e-01 | 0.125 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.496631e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.496631e-01 | 0.125 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.523087e-01 | 0.124 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.523087e-01 | 0.124 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.568616e-01 | 0.121 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.568616e-01 | 0.121 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.568616e-01 | 0.121 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.568616e-01 | 0.121 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.572086e-01 | 0.121 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.572262e-01 | 0.121 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.576996e-01 | 0.121 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.593985e-01 | 0.120 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.593985e-01 | 0.120 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.593985e-01 | 0.120 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.593985e-01 | 0.120 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.593985e-01 | 0.120 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.593985e-01 | 0.120 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.593985e-01 | 0.120 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.602758e-01 | 0.119 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.607195e-01 | 0.119 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.610952e-01 | 0.119 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.651080e-01 | 0.116 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.666467e-01 | 0.115 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.672756e-01 | 0.115 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.672756e-01 | 0.115 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.693485e-01 | 0.114 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.693485e-01 | 0.114 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.715880e-01 | 0.113 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.772241e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.772241e-01 | 0.109 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.772241e-01 | 0.109 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.772241e-01 | 0.109 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.772241e-01 | 0.109 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.772241e-01 | 0.109 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.798149e-01 | 0.108 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.799378e-01 | 0.108 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.799378e-01 | 0.108 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.838640e-01 | 0.106 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.838640e-01 | 0.106 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.838640e-01 | 0.106 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.838640e-01 | 0.106 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.846434e-01 | 0.105 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.863421e-01 | 0.104 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.863421e-01 | 0.104 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.863421e-01 | 0.104 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.863421e-01 | 0.104 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.863421e-01 | 0.104 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.863421e-01 | 0.104 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.863421e-01 | 0.104 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.863421e-01 | 0.104 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.863421e-01 | 0.104 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.863421e-01 | 0.104 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.926559e-01 | 0.101 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.926559e-01 | 0.101 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.926559e-01 | 0.101 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.932719e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.932719e-01 | 0.101 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.934962e-01 | 0.100 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.940151e-01 | 0.100 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.940151e-01 | 0.100 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.940151e-01 | 0.100 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.956077e-01 | 0.099 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.956077e-01 | 0.099 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.960769e-01 | 0.099 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.960769e-01 | 0.099 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.994617e-01 | 0.097 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.994617e-01 | 0.097 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.994617e-01 | 0.097 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.048196e-01 | 0.094 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.049032e-01 | 0.094 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.049032e-01 | 0.094 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.054604e-01 | 0.094 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.073585e-01 | 0.093 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.073585e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.073585e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.073585e-01 | 0.093 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.083404e-01 | 0.092 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.102698e-01 | 0.091 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.102698e-01 | 0.091 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.102698e-01 | 0.091 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.102698e-01 | 0.091 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.102698e-01 | 0.091 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.102698e-01 | 0.091 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.102698e-01 | 0.091 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.102698e-01 | 0.091 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.102698e-01 | 0.091 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.102698e-01 | 0.091 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.102698e-01 | 0.091 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.102698e-01 | 0.091 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.102698e-01 | 0.091 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.102698e-01 | 0.091 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.102698e-01 | 0.091 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.102698e-01 | 0.091 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.102698e-01 | 0.091 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.110915e-01 | 0.091 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.135026e-01 | 0.090 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.135026e-01 | 0.090 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.135026e-01 | 0.090 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.135026e-01 | 0.090 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.135026e-01 | 0.090 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.135026e-01 | 0.090 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.135026e-01 | 0.090 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.141044e-01 | 0.089 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.141044e-01 | 0.089 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.141044e-01 | 0.089 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.156538e-01 | 0.088 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.162576e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.165695e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.170695e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.170695e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.178256e-01 | 0.087 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.178256e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.191295e-01 | 0.087 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.248917e-01 | 0.084 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.255234e-01 | 0.083 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.259566e-01 | 0.083 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.265418e-01 | 0.083 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.269454e-01 | 0.083 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.276689e-01 | 0.082 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.281111e-01 | 0.082 | 1 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.295844e-01 | 0.081 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.295844e-01 | 0.081 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.307793e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.307793e-01 | 0.081 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.307793e-01 | 0.081 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.315191e-01 | 0.080 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.315191e-01 | 0.080 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.315191e-01 | 0.080 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.315191e-01 | 0.080 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.315191e-01 | 0.080 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.315191e-01 | 0.080 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.315191e-01 | 0.080 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.319279e-01 | 0.080 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.319279e-01 | 0.080 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.319279e-01 | 0.080 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.319279e-01 | 0.080 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.358944e-01 | 0.078 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.358944e-01 | 0.078 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.406770e-01 | 0.075 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.407160e-01 | 0.075 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.430515e-01 | 0.074 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.430515e-01 | 0.074 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.444046e-01 | 0.073 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.444046e-01 | 0.073 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.499209e-01 | 0.071 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.503896e-01 | 0.070 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.503896e-01 | 0.070 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.503896e-01 | 0.070 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.503896e-01 | 0.070 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.503896e-01 | 0.070 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.503896e-01 | 0.070 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.503896e-01 | 0.070 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.503896e-01 | 0.070 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.503896e-01 | 0.070 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.503896e-01 | 0.070 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.503896e-01 | 0.070 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.503896e-01 | 0.070 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.503896e-01 | 0.070 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.524137e-01 | 0.069 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.526859e-01 | 0.069 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.526859e-01 | 0.069 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.534888e-01 | 0.069 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.534888e-01 | 0.069 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.536593e-01 | 0.069 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.563973e-01 | 0.067 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.580441e-01 | 0.066 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.580441e-01 | 0.066 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.607715e-01 | 0.065 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.630971e-01 | 0.064 | 1 | 0 |
| G1 Phase | R-HSA-69236 | 8.638367e-01 | 0.064 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.638367e-01 | 0.064 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.638367e-01 | 0.064 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.638367e-01 | 0.064 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.638966e-01 | 0.064 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.638966e-01 | 0.064 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.638966e-01 | 0.064 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.671475e-01 | 0.062 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.671475e-01 | 0.062 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.671475e-01 | 0.062 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.671475e-01 | 0.062 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.671475e-01 | 0.062 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.671475e-01 | 0.062 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.671475e-01 | 0.062 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.671475e-01 | 0.062 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.671475e-01 | 0.062 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.671475e-01 | 0.062 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.672989e-01 | 0.062 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.675094e-01 | 0.062 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.705813e-01 | 0.060 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.705813e-01 | 0.060 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.705813e-01 | 0.060 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.705813e-01 | 0.060 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.705813e-01 | 0.060 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.705813e-01 | 0.060 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.732528e-01 | 0.059 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.737187e-01 | 0.059 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.741928e-01 | 0.058 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.743495e-01 | 0.058 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.743495e-01 | 0.058 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.743495e-01 | 0.058 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.743495e-01 | 0.058 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.752193e-01 | 0.058 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.775931e-01 | 0.057 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.802039e-01 | 0.055 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.820292e-01 | 0.055 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.820292e-01 | 0.055 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.820292e-01 | 0.055 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.820292e-01 | 0.055 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.820292e-01 | 0.055 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.820292e-01 | 0.055 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.820292e-01 | 0.055 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.820292e-01 | 0.055 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.820292e-01 | 0.055 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.820292e-01 | 0.055 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.820292e-01 | 0.055 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.820921e-01 | 0.054 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.820921e-01 | 0.054 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.820921e-01 | 0.054 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.820921e-01 | 0.054 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.821009e-01 | 0.054 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.840844e-01 | 0.054 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.864135e-01 | 0.052 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.864135e-01 | 0.052 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.880046e-01 | 0.052 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.880046e-01 | 0.052 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.880046e-01 | 0.052 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.904067e-01 | 0.050 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.904067e-01 | 0.050 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.916336e-01 | 0.050 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.926489e-01 | 0.049 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.926489e-01 | 0.049 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.926489e-01 | 0.049 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.926489e-01 | 0.049 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.926489e-01 | 0.049 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.929360e-01 | 0.049 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.931404e-01 | 0.049 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.931404e-01 | 0.049 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.931404e-01 | 0.049 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.952447e-01 | 0.048 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.952447e-01 | 0.048 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.952447e-01 | 0.048 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.952447e-01 | 0.048 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.952447e-01 | 0.048 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.952447e-01 | 0.048 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.952447e-01 | 0.048 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.952447e-01 | 0.048 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.952447e-01 | 0.048 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.952447e-01 | 0.048 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.952447e-01 | 0.048 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.952447e-01 | 0.048 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.005565e-01 | 0.045 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.015560e-01 | 0.045 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.023211e-01 | 0.045 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.023211e-01 | 0.045 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.023211e-01 | 0.045 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.023211e-01 | 0.045 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.023211e-01 | 0.045 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.023211e-01 | 0.045 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.023696e-01 | 0.045 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.047701e-01 | 0.043 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.047701e-01 | 0.043 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.047701e-01 | 0.043 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.047701e-01 | 0.043 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.047701e-01 | 0.043 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.047701e-01 | 0.043 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.052372e-01 | 0.043 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.069805e-01 | 0.042 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.069805e-01 | 0.042 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.069805e-01 | 0.042 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.069805e-01 | 0.042 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.069805e-01 | 0.042 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.069805e-01 | 0.042 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.069805e-01 | 0.042 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.069805e-01 | 0.042 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.070993e-01 | 0.042 | 1 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.108855e-01 | 0.041 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.111742e-01 | 0.040 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.111742e-01 | 0.040 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.111742e-01 | 0.040 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.149803e-01 | 0.039 | 1 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.166139e-01 | 0.038 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.166139e-01 | 0.038 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.166139e-01 | 0.038 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.174021e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.174021e-01 | 0.037 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.174021e-01 | 0.037 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.174021e-01 | 0.037 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.174021e-01 | 0.037 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.174021e-01 | 0.037 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.174021e-01 | 0.037 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.174021e-01 | 0.037 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.187071e-01 | 0.037 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.192704e-01 | 0.037 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.192704e-01 | 0.037 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.192704e-01 | 0.037 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.225582e-01 | 0.035 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.229588e-01 | 0.035 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.233273e-01 | 0.035 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.241696e-01 | 0.034 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.246731e-01 | 0.034 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.266566e-01 | 0.033 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.266566e-01 | 0.033 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.266566e-01 | 0.033 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.266566e-01 | 0.033 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.266566e-01 | 0.033 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.266566e-01 | 0.033 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.266566e-01 | 0.033 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.266681e-01 | 0.033 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.266681e-01 | 0.033 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.266681e-01 | 0.033 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.295422e-01 | 0.032 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.302422e-01 | 0.031 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.302422e-01 | 0.031 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.308429e-01 | 0.031 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.318176e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.322141e-01 | 0.030 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.331535e-01 | 0.030 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.331863e-01 | 0.030 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.332213e-01 | 0.030 | 1 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.334221e-01 | 0.030 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.334221e-01 | 0.030 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.334221e-01 | 0.030 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.335509e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.348747e-01 | 0.029 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.348747e-01 | 0.029 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.348747e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.348747e-01 | 0.029 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.348747e-01 | 0.029 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.348747e-01 | 0.029 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.352905e-01 | 0.029 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.352905e-01 | 0.029 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.354363e-01 | 0.029 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.359228e-01 | 0.029 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.363568e-01 | 0.029 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.366968e-01 | 0.028 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.374720e-01 | 0.028 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.389219e-01 | 0.027 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.395838e-01 | 0.027 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.395838e-01 | 0.027 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.406031e-01 | 0.027 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.406031e-01 | 0.027 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.407887e-01 | 0.027 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.407887e-01 | 0.027 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.407887e-01 | 0.027 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.417629e-01 | 0.026 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.421724e-01 | 0.026 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.421724e-01 | 0.026 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.421724e-01 | 0.026 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.421724e-01 | 0.026 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.422199e-01 | 0.026 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.447846e-01 | 0.025 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.452011e-01 | 0.024 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.455089e-01 | 0.024 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.455089e-01 | 0.024 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.486527e-01 | 0.023 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.486527e-01 | 0.023 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.486527e-01 | 0.023 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.486527e-01 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.486527e-01 | 0.023 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.486527e-01 | 0.023 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.486527e-01 | 0.023 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.486527e-01 | 0.023 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.486527e-01 | 0.023 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.500358e-01 | 0.022 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.500358e-01 | 0.022 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.500358e-01 | 0.022 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.500358e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.503186e-01 | 0.022 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.503186e-01 | 0.022 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.503186e-01 | 0.022 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.503186e-01 | 0.022 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.528792e-01 | 0.021 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.534703e-01 | 0.021 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.541783e-01 | 0.020 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.544072e-01 | 0.020 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.544072e-01 | 0.020 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.544072e-01 | 0.020 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.544072e-01 | 0.020 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.544072e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.544072e-01 | 0.020 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.544072e-01 | 0.020 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.548173e-01 | 0.020 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.549777e-01 | 0.020 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.549777e-01 | 0.020 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.549777e-01 | 0.020 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.549777e-01 | 0.020 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.549777e-01 | 0.020 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.549777e-01 | 0.020 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.549777e-01 | 0.020 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.553063e-01 | 0.020 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.559803e-01 | 0.020 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.565032e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.565032e-01 | 0.019 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.568101e-01 | 0.019 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.568101e-01 | 0.019 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.568101e-01 | 0.019 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.572440e-01 | 0.019 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.575645e-01 | 0.019 | 1 | 1 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.581364e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.592169e-01 | 0.018 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.592169e-01 | 0.018 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.592169e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.595171e-01 | 0.018 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.595171e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.595171e-01 | 0.018 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.595171e-01 | 0.018 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.595171e-01 | 0.018 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.595171e-01 | 0.018 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.596586e-01 | 0.018 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.615973e-01 | 0.017 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.615973e-01 | 0.017 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.621715e-01 | 0.017 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.628408e-01 | 0.016 | 1 | 1 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.629906e-01 | 0.016 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.629906e-01 | 0.016 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.630717e-01 | 0.016 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.630717e-01 | 0.016 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.630717e-01 | 0.016 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.640545e-01 | 0.016 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.640545e-01 | 0.016 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.640545e-01 | 0.016 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.640545e-01 | 0.016 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.640545e-01 | 0.016 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.640545e-01 | 0.016 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.640545e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.646663e-01 | 0.016 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.648561e-01 | 0.016 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.650732e-01 | 0.015 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.655566e-01 | 0.015 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.658862e-01 | 0.015 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.665751e-01 | 0.015 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.665751e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.665751e-01 | 0.015 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.665751e-01 | 0.015 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.665751e-01 | 0.015 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.680836e-01 | 0.014 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.680836e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.680836e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.680836e-01 | 0.014 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.680836e-01 | 0.014 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.680836e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.680836e-01 | 0.014 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.710549e-01 | 0.013 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.716613e-01 | 0.012 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.716613e-01 | 0.012 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.716613e-01 | 0.012 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.716613e-01 | 0.012 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.726433e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.726433e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.726463e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.748381e-01 | 0.011 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.748381e-01 | 0.011 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.748381e-01 | 0.011 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.748381e-01 | 0.011 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.752679e-01 | 0.011 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.752679e-01 | 0.011 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.752679e-01 | 0.011 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.752679e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.774512e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.775892e-01 | 0.010 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.776457e-01 | 0.010 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.776457e-01 | 0.010 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.776457e-01 | 0.010 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.776590e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.776590e-01 | 0.010 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.776590e-01 | 0.010 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.776590e-01 | 0.010 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.776590e-01 | 0.010 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.776590e-01 | 0.010 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.789924e-01 | 0.009 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.795428e-01 | 0.009 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.795428e-01 | 0.009 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.795428e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.801638e-01 | 0.009 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.801638e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.812220e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.812220e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.813333e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.823878e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.823878e-01 | 0.008 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.823878e-01 | 0.008 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.823878e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.825841e-01 | 0.008 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.829364e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.829734e-01 | 0.007 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.830690e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.838534e-01 | 0.007 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.838738e-01 | 0.007 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.843627e-01 | 0.007 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.844750e-01 | 0.007 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.850335e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.850335e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.851265e-01 | 0.007 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.861162e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.861162e-01 | 0.006 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.866970e-01 | 0.006 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.870669e-01 | 0.006 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.870823e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.871063e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.871063e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.871063e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.876731e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.876731e-01 | 0.005 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.876731e-01 | 0.005 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.878888e-01 | 0.005 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.878888e-01 | 0.005 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.878888e-01 | 0.005 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.878888e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.882557e-01 | 0.005 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.886145e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.890556e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.901484e-01 | 0.004 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.902657e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.902830e-01 | 0.004 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.902830e-01 | 0.004 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.903304e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.910965e-01 | 0.004 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.912900e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.913729e-01 | 0.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.922259e-01 | 0.003 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.923406e-01 | 0.003 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.923406e-01 | 0.003 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.923406e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.926717e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.926903e-01 | 0.003 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.927860e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.927860e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.931998e-01 | 0.003 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.935007e-01 | 0.003 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.938616e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.938809e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.939443e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.939626e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.941356e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.942722e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.946400e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.946400e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.946400e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.950015e-01 | 0.002 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.952413e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.952413e-01 | 0.002 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.952413e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.954084e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.954606e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.954606e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.957752e-01 | 0.002 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.957752e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.959480e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.962493e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.962493e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.966052e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.966702e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.966702e-01 | 0.001 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.967709e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.967727e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.968350e-01 | 0.001 | 1 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.970439e-01 | 0.001 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.970439e-01 | 0.001 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.970439e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.970439e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.970439e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.973756e-01 | 0.001 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.976702e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.977035e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.977035e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.977502e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.978122e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.979317e-01 | 0.001 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.981638e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.982911e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.983352e-01 | 0.001 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.983557e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.983699e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.985699e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.986726e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.987018e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.987727e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988076e-01 | 0.001 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.988076e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.989221e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989791e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.989818e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989877e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.991013e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.991364e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.992866e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.992918e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.993120e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993809e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994394e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.994531e-01 | 0.000 | 1 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.995603e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.995773e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.996097e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.996535e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.996535e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996775e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.996925e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.996925e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.996925e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997270e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.997366e-01 | 0.000 | 1 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.997712e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997849e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998642e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998665e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998870e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999171e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999347e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999359e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999517e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999596e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999640e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999681e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999710e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999714e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999749e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999768e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999824e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999848e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999877e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999923e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999924e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999924e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999939e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999956e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999957e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999971e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999977e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999982e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999984e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999984e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999985e-01 | 0.000 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999987e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999990e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999995e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 7.165379e-13 | 12.145 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.781442e-12 | 11.556 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.593714e-11 | 10.798 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.687606e-11 | 10.571 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.889240e-10 | 9.724 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.279274e-08 | 7.642 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.446160e-08 | 7.612 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.409196e-07 | 6.851 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.131436e-07 | 6.671 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.437248e-07 | 6.613 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.180856e-07 | 6.379 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.702282e-07 | 6.328 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.975071e-07 | 6.303 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.031995e-07 | 6.095 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.522179e-07 | 6.069 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.942710e-07 | 6.002 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.600446e-07 | 6.018 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.171256e-06 | 5.931 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.250804e-06 | 5.903 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.809387e-06 | 5.742 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.067954e-06 | 5.684 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.771774e-06 | 5.557 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.591455e-06 | 5.586 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.591455e-06 | 5.586 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.740330e-06 | 5.562 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.660373e-06 | 5.575 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.924912e-06 | 5.534 | 1 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.787855e-06 | 5.422 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.787855e-06 | 5.422 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.643442e-06 | 5.438 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.706996e-06 | 5.431 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.953155e-06 | 5.305 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.702210e-06 | 5.244 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.716437e-06 | 5.243 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.716437e-06 | 5.243 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.141885e-06 | 5.212 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.352211e-06 | 5.197 | 1 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.741183e-06 | 5.171 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.703936e-06 | 5.174 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.291291e-06 | 5.137 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.710491e-06 | 5.113 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.779190e-06 | 5.109 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.615481e-06 | 5.118 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.130632e-06 | 5.090 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.660986e-06 | 5.062 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.041447e-05 | 4.982 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.575766e-05 | 4.803 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.647530e-05 | 4.783 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.926140e-05 | 4.715 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.095440e-05 | 4.679 | 1 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.580894e-05 | 4.588 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.580894e-05 | 4.588 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.504258e-05 | 4.601 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.516628e-05 | 4.599 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.801853e-05 | 4.553 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.129428e-05 | 4.505 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.325358e-05 | 4.478 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.534412e-05 | 4.452 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.569312e-05 | 4.447 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.789209e-05 | 4.421 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.112876e-05 | 4.386 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.356068e-05 | 4.361 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.743732e-05 | 4.324 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.743732e-05 | 4.324 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.125600e-05 | 4.290 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.158191e-05 | 4.288 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.495062e-05 | 4.260 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.338784e-05 | 4.198 | 1 | 1 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.374717e-05 | 4.196 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.718291e-05 | 4.173 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.722148e-05 | 4.172 | 1 | 1 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.079358e-05 | 4.150 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.854756e-05 | 4.105 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.547796e-05 | 4.068 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.856226e-05 | 4.053 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.132507e-05 | 4.039 | 1 | 1 |
| Programmed Cell Death | R-HSA-5357801 | 9.652062e-05 | 4.015 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.126684e-04 | 3.948 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.089911e-04 | 3.963 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.074349e-04 | 3.969 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.090164e-04 | 3.963 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.107516e-04 | 3.956 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.054724e-04 | 3.977 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.105962e-04 | 3.956 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.269838e-04 | 3.896 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.327226e-04 | 3.877 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.488769e-04 | 3.827 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.426311e-04 | 3.846 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.598023e-04 | 3.796 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.810000e-04 | 3.742 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.759481e-04 | 3.755 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.759481e-04 | 3.755 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.778871e-04 | 3.750 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.755497e-04 | 3.756 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.885892e-04 | 3.724 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.885892e-04 | 3.724 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.885892e-04 | 3.724 | 1 | 1 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.885892e-04 | 3.724 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.885892e-04 | 3.724 | 1 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.928898e-04 | 3.715 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.024165e-04 | 3.694 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.241531e-04 | 3.649 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.295162e-04 | 3.639 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.446478e-04 | 3.611 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.878832e-04 | 3.541 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.729860e-04 | 3.564 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.201954e-04 | 3.495 | 1 | 0 |
| Meiosis | R-HSA-1500620 | 3.201954e-04 | 3.495 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.257043e-04 | 3.487 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.257043e-04 | 3.487 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.275313e-04 | 3.485 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.510531e-04 | 3.455 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.550614e-04 | 3.450 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.489648e-04 | 3.457 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.558050e-04 | 3.449 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.622972e-04 | 3.441 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.663790e-04 | 3.436 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.136201e-04 | 3.383 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.386066e-04 | 3.358 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.894737e-04 | 3.310 | 1 | 1 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.027542e-04 | 3.299 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.211116e-04 | 3.283 | 1 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.383286e-04 | 3.269 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.383286e-04 | 3.269 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.398289e-04 | 3.268 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.478990e-04 | 3.261 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.572126e-04 | 3.254 | 1 | 1 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.153710e-04 | 3.211 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.196534e-04 | 3.208 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.406635e-04 | 3.193 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.427893e-04 | 3.192 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.126090e-04 | 3.147 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.431311e-04 | 3.129 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.880672e-04 | 3.103 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.194274e-04 | 3.086 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.686591e-04 | 3.061 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.699659e-04 | 3.060 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.536059e-04 | 3.021 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.042471e-03 | 2.982 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.042471e-03 | 2.982 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.042471e-03 | 2.982 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.652745e-04 | 3.015 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.100098e-03 | 2.959 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.136715e-03 | 2.944 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.147989e-03 | 2.940 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.151029e-03 | 2.939 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.225469e-03 | 2.912 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.332606e-03 | 2.875 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.262473e-03 | 2.899 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.262473e-03 | 2.899 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.255439e-03 | 2.901 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.355182e-03 | 2.868 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.370834e-03 | 2.863 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.287553e-03 | 2.890 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.398059e-03 | 2.854 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.550924e-03 | 2.809 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.590815e-03 | 2.798 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.599722e-03 | 2.796 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.599722e-03 | 2.796 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.863823e-03 | 2.730 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.903860e-03 | 2.720 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.948629e-03 | 2.710 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.955007e-03 | 2.709 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.032272e-03 | 2.692 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.102738e-03 | 2.677 | 1 | 1 |
| Opioid Signalling | R-HSA-111885 | 2.126058e-03 | 2.672 | 1 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.144716e-03 | 2.669 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.151491e-03 | 2.667 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.397527e-03 | 2.620 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.397527e-03 | 2.620 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.165577e-03 | 2.664 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.397527e-03 | 2.620 | 1 | 1 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.320425e-03 | 2.634 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.397527e-03 | 2.620 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.476498e-03 | 2.606 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.497700e-03 | 2.602 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.548684e-03 | 2.594 | 1 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.609092e-03 | 2.584 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.647453e-03 | 2.577 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.781977e-03 | 2.556 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.857369e-03 | 2.544 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.903055e-03 | 2.537 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.132732e-03 | 2.504 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.132732e-03 | 2.504 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.151429e-03 | 2.501 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.437097e-03 | 2.464 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.586229e-03 | 2.445 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.193334e-03 | 2.496 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.392125e-03 | 2.470 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.211114e-03 | 2.493 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.211114e-03 | 2.493 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.353299e-03 | 2.475 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.727325e-03 | 2.429 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.780770e-03 | 2.422 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.836058e-03 | 2.416 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.066843e-03 | 2.391 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.202078e-03 | 2.377 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.387090e-03 | 2.358 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.387090e-03 | 2.358 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.423039e-03 | 2.354 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.444352e-03 | 2.352 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.506631e-03 | 2.346 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.506631e-03 | 2.346 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.521595e-03 | 2.345 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.624712e-03 | 2.335 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.779414e-03 | 2.321 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.125474e-03 | 2.290 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.125474e-03 | 2.290 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.125474e-03 | 2.290 | 1 | 1 |
| Recycling pathway of L1 | R-HSA-437239 | 4.976185e-03 | 2.303 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.338966e-03 | 2.273 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.338966e-03 | 2.273 | 1 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.217730e-03 | 2.283 | 1 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.779414e-03 | 2.321 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.202418e-03 | 2.284 | 1 | 1 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.110901e-03 | 2.292 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.761864e-03 | 2.322 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.062638e-03 | 2.296 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.496321e-03 | 2.260 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.553801e-03 | 2.255 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.682456e-03 | 2.245 | 1 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.779187e-03 | 2.238 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.779187e-03 | 2.238 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.797838e-03 | 2.237 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.867587e-03 | 2.232 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.059960e-03 | 2.218 | 1 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.061275e-03 | 2.217 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.061815e-03 | 2.217 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.061815e-03 | 2.217 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.288121e-03 | 2.201 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.288121e-03 | 2.201 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.288121e-03 | 2.201 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.327342e-03 | 2.199 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.331313e-03 | 2.199 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.386116e-03 | 2.195 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.189933e-03 | 2.143 | 1 | 1 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.189933e-03 | 2.143 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.549330e-03 | 2.122 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.170422e-03 | 2.144 | 1 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.426964e-03 | 2.129 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.471954e-03 | 2.189 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.025683e-03 | 2.153 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.004159e-03 | 2.155 | 1 | 1 |
| Semaphorin interactions | R-HSA-373755 | 7.270101e-03 | 2.138 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.825131e-03 | 2.166 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.004159e-03 | 2.155 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.189933e-03 | 2.143 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.364782e-03 | 2.133 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.718086e-03 | 2.173 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.567504e-03 | 2.121 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.085760e-03 | 2.092 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.227221e-03 | 2.085 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.311676e-03 | 2.080 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.343264e-03 | 2.079 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.562166e-03 | 2.067 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.820182e-03 | 2.055 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.839122e-03 | 2.054 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.923555e-03 | 2.049 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.317731e-03 | 2.031 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 9.536735e-03 | 2.021 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.556477e-03 | 2.020 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.556477e-03 | 2.020 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.556477e-03 | 2.020 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.556477e-03 | 2.020 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.579489e-03 | 2.019 | 1 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.944740e-03 | 2.002 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.944740e-03 | 2.002 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.944740e-03 | 2.002 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.026929e-02 | 1.988 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.045823e-02 | 1.981 | 1 | 1 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.045823e-02 | 1.981 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.045823e-02 | 1.981 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.060713e-02 | 1.974 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.066259e-02 | 1.972 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.109653e-02 | 1.955 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.109653e-02 | 1.955 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.115946e-02 | 1.952 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.168445e-02 | 1.932 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.411969e-02 | 1.850 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.411969e-02 | 1.850 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.411969e-02 | 1.850 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.270956e-02 | 1.896 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.307480e-02 | 1.884 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.316892e-02 | 1.880 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.230158e-02 | 1.910 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.411969e-02 | 1.850 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.271618e-02 | 1.896 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.411952e-02 | 1.850 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.411969e-02 | 1.850 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.393667e-02 | 1.856 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.485897e-02 | 1.828 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.490665e-02 | 1.827 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.490665e-02 | 1.827 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.490665e-02 | 1.827 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.505121e-02 | 1.822 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.505121e-02 | 1.822 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.510757e-02 | 1.821 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.518316e-02 | 1.819 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.525020e-02 | 1.817 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.577997e-02 | 1.802 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.586975e-02 | 1.799 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.612936e-02 | 1.792 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.627925e-02 | 1.788 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.627925e-02 | 1.788 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.654070e-02 | 1.781 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.767361e-02 | 1.753 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.780423e-02 | 1.749 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.804089e-02 | 1.744 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.804089e-02 | 1.744 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.804089e-02 | 1.744 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.804089e-02 | 1.744 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.804089e-02 | 1.744 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.804089e-02 | 1.744 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.848274e-02 | 1.733 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.866317e-02 | 1.729 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.913707e-02 | 1.718 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.918723e-02 | 1.717 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.925233e-02 | 1.716 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.925233e-02 | 1.716 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.991512e-02 | 1.701 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.012041e-02 | 1.696 | 1 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.012041e-02 | 1.696 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.504960e-02 | 1.601 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.419796e-02 | 1.616 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.409053e-02 | 1.618 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.404565e-02 | 1.619 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.265551e-02 | 1.645 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.059248e-02 | 1.686 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.123873e-02 | 1.673 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.206509e-02 | 1.656 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.206509e-02 | 1.656 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.504960e-02 | 1.601 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.504960e-02 | 1.601 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.317028e-02 | 1.635 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.130008e-02 | 1.672 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.504960e-02 | 1.601 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.551143e-02 | 1.593 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.615872e-02 | 1.582 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.631730e-02 | 1.580 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.662192e-02 | 1.575 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.700892e-02 | 1.568 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.700892e-02 | 1.568 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.700892e-02 | 1.568 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.700892e-02 | 1.568 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.700892e-02 | 1.568 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.736938e-02 | 1.563 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.919735e-02 | 1.535 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.023378e-02 | 1.520 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.024124e-02 | 1.519 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.036009e-02 | 1.518 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.043679e-02 | 1.517 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.074172e-02 | 1.512 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.082634e-02 | 1.511 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.086363e-02 | 1.511 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.106702e-02 | 1.508 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.129233e-02 | 1.505 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.129233e-02 | 1.505 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.171302e-02 | 1.499 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.188561e-02 | 1.496 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.188561e-02 | 1.496 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.263889e-02 | 1.486 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.312940e-02 | 1.480 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.365509e-02 | 1.473 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.365509e-02 | 1.473 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.427585e-02 | 1.465 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.427585e-02 | 1.465 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.431180e-02 | 1.465 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.448358e-02 | 1.462 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.539491e-02 | 1.451 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.539491e-02 | 1.451 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.539491e-02 | 1.451 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.539491e-02 | 1.451 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.539491e-02 | 1.451 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.548007e-02 | 1.450 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.548007e-02 | 1.450 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.583481e-02 | 1.446 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.663041e-02 | 1.436 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.788081e-02 | 1.422 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.790647e-02 | 1.421 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.790647e-02 | 1.421 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.790647e-02 | 1.421 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.799177e-02 | 1.420 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.799177e-02 | 1.420 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.923272e-02 | 1.308 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.460691e-02 | 1.351 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.460691e-02 | 1.351 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.638316e-02 | 1.334 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.638316e-02 | 1.334 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.097899e-02 | 1.293 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.073279e-02 | 1.295 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.145585e-02 | 1.382 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.648293e-02 | 1.333 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.638316e-02 | 1.334 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.680190e-02 | 1.330 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.097899e-02 | 1.293 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.648293e-02 | 1.333 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.732873e-02 | 1.325 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.100162e-02 | 1.387 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.648034e-02 | 1.333 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.870430e-02 | 1.312 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.842938e-02 | 1.415 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.895463e-02 | 1.310 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.338077e-02 | 1.363 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.761966e-02 | 1.322 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.951973e-02 | 1.305 | 1 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.446568e-02 | 1.352 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.772336e-02 | 1.321 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.460691e-02 | 1.351 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.867531e-02 | 1.413 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.648293e-02 | 1.333 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.648293e-02 | 1.333 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.169714e-02 | 1.380 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.023984e-02 | 1.299 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.648293e-02 | 1.333 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.512448e-02 | 1.346 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.200173e-02 | 1.284 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.200173e-02 | 1.284 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.412507e-02 | 1.267 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.433786e-02 | 1.265 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.433786e-02 | 1.265 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.433786e-02 | 1.265 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.546500e-02 | 1.256 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.546500e-02 | 1.256 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.587188e-02 | 1.253 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.619787e-02 | 1.250 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.813832e-02 | 1.236 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.815125e-02 | 1.235 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.977342e-02 | 1.223 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.005416e-02 | 1.221 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.010033e-02 | 1.221 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.135764e-02 | 1.212 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.161880e-02 | 1.210 | 1 | 1 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.315494e-02 | 1.200 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.315494e-02 | 1.200 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.325183e-02 | 1.199 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.325183e-02 | 1.199 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.469466e-02 | 1.189 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.519191e-02 | 1.186 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.537774e-02 | 1.185 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.537774e-02 | 1.185 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.537774e-02 | 1.185 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.537774e-02 | 1.185 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.549496e-02 | 1.184 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.575402e-02 | 1.182 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.606424e-02 | 1.180 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.638347e-02 | 1.178 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.638347e-02 | 1.178 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.638347e-02 | 1.178 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.843430e-02 | 1.165 | 1 | 1 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.859460e-02 | 1.164 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.859460e-02 | 1.164 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.859460e-02 | 1.164 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.859460e-02 | 1.164 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.859460e-02 | 1.164 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.890673e-02 | 1.162 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.946750e-02 | 1.158 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.946750e-02 | 1.158 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.946750e-02 | 1.158 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.964540e-02 | 1.157 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.993504e-02 | 1.155 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.033971e-02 | 1.153 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.034513e-02 | 1.153 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.108381e-02 | 1.148 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.130203e-02 | 1.147 | 1 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.236961e-02 | 1.140 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.311704e-02 | 1.136 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.495885e-02 | 1.125 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.660838e-02 | 1.015 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.660838e-02 | 1.015 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.660838e-02 | 1.015 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.660838e-02 | 1.015 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.660838e-02 | 1.015 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.660838e-02 | 1.015 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.660838e-02 | 1.015 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.660838e-02 | 1.015 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.261025e-02 | 1.033 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.261025e-02 | 1.033 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.261025e-02 | 1.033 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.320321e-02 | 1.080 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.320321e-02 | 1.080 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.030828e-01 | 0.987 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.227590e-02 | 1.085 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.227590e-02 | 1.085 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.227590e-02 | 1.085 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.227590e-02 | 1.085 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.227590e-02 | 1.085 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.227590e-02 | 1.085 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.227590e-02 | 1.085 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.227590e-02 | 1.085 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.621384e-02 | 1.118 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.863252e-02 | 1.052 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.041181e-01 | 0.982 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.777692e-02 | 1.010 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.777692e-02 | 1.010 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.943744e-02 | 1.100 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.013059e-01 | 0.994 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.447384e-02 | 1.025 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.635193e-02 | 1.064 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.005834e-01 | 0.997 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.642056e-02 | 1.016 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.111083e-01 | 0.954 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.065245e-01 | 0.973 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.132828e-01 | 0.946 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.132828e-01 | 0.946 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.687162e-02 | 1.061 | 1 | 1 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.041816e-01 | 0.982 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.118874e-01 | 0.951 | 1 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.927487e-02 | 1.049 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.927487e-02 | 1.049 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.387388e-02 | 1.076 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.844011e-02 | 1.053 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.575947e-02 | 1.019 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.575947e-02 | 1.019 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.575947e-02 | 1.019 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.112078e-01 | 0.954 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.243426e-02 | 1.034 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 8.320321e-02 | 1.080 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.111083e-01 | 0.954 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.593407e-02 | 1.120 | 1 | 1 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.065245e-01 | 0.973 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.478872e-02 | 1.023 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.353560e-02 | 1.029 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.795716e-02 | 1.056 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.555655e-02 | 1.068 | 1 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.575947e-02 | 1.019 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.507925e-02 | 1.070 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.170901e-02 | 1.038 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.227590e-02 | 1.085 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.642056e-02 | 1.016 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.106438e-01 | 0.956 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.036116e-01 | 0.985 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.128770e-01 | 0.947 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.687162e-02 | 1.061 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.227590e-02 | 1.085 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.227590e-02 | 1.085 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.065245e-01 | 0.973 | 1 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.028261e-02 | 1.044 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.056254e-01 | 0.976 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.863252e-02 | 1.052 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.863252e-02 | 1.052 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.106438e-01 | 0.956 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.132828e-01 | 0.946 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.780505e-02 | 1.056 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.687162e-02 | 1.061 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.289674e-02 | 1.081 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.052715e-02 | 1.094 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.041181e-01 | 0.982 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.564917e-02 | 1.019 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.138253e-01 | 0.944 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.138747e-01 | 0.944 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.140608e-01 | 0.943 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.140608e-01 | 0.943 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.174227e-01 | 0.930 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.192113e-01 | 0.924 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.193381e-01 | 0.923 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.218872e-01 | 0.914 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.223725e-01 | 0.912 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.223725e-01 | 0.912 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.233349e-01 | 0.909 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.233349e-01 | 0.909 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.233349e-01 | 0.909 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.233349e-01 | 0.909 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.246285e-01 | 0.904 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.250404e-01 | 0.903 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.250404e-01 | 0.903 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.250404e-01 | 0.903 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.250404e-01 | 0.903 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.271038e-01 | 0.896 | 1 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.283504e-01 | 0.892 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.283512e-01 | 0.892 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.283512e-01 | 0.892 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.283512e-01 | 0.892 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.291662e-01 | 0.889 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.291662e-01 | 0.889 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.291662e-01 | 0.889 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.304178e-01 | 0.885 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.304178e-01 | 0.885 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.304178e-01 | 0.885 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.304178e-01 | 0.885 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.316348e-01 | 0.881 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.325186e-01 | 0.878 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.328048e-01 | 0.877 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.359883e-01 | 0.866 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.361894e-01 | 0.866 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.361894e-01 | 0.866 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.361894e-01 | 0.866 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.361894e-01 | 0.866 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.361894e-01 | 0.866 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.367221e-01 | 0.864 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.400420e-01 | 0.854 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.404869e-01 | 0.852 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.414915e-01 | 0.849 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.434105e-01 | 0.843 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.476280e-01 | 0.831 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.476280e-01 | 0.831 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.476280e-01 | 0.831 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.484000e-01 | 0.829 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.485715e-01 | 0.828 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.485715e-01 | 0.828 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.485715e-01 | 0.828 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.485715e-01 | 0.828 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.496441e-01 | 0.825 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.506528e-01 | 0.822 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.517806e-01 | 0.819 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.526688e-01 | 0.816 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.537019e-01 | 0.813 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.562399e-01 | 0.806 | 1 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.586289e-01 | 0.800 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.591898e-01 | 0.798 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.596756e-01 | 0.797 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.596756e-01 | 0.797 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 1.596756e-01 | 0.797 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.596756e-01 | 0.797 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.596756e-01 | 0.797 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.599135e-01 | 0.796 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.599135e-01 | 0.796 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.599135e-01 | 0.796 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.599135e-01 | 0.796 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.599135e-01 | 0.796 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.599135e-01 | 0.796 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.613669e-01 | 0.792 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.624275e-01 | 0.789 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.636677e-01 | 0.786 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.636677e-01 | 0.786 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.639537e-01 | 0.785 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.648878e-01 | 0.783 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.648878e-01 | 0.783 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.838887e-01 | 0.735 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.838887e-01 | 0.735 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.838887e-01 | 0.735 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.838887e-01 | 0.735 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.838887e-01 | 0.735 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.838887e-01 | 0.735 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.838887e-01 | 0.735 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.838887e-01 | 0.735 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.627412e-01 | 0.580 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.627412e-01 | 0.580 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.627412e-01 | 0.580 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.627412e-01 | 0.580 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.627412e-01 | 0.580 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.627412e-01 | 0.580 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.627412e-01 | 0.580 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.627412e-01 | 0.580 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.627412e-01 | 0.580 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.957878e-01 | 0.708 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 1.957878e-01 | 0.708 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.957878e-01 | 0.708 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.957878e-01 | 0.708 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.957878e-01 | 0.708 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.957878e-01 | 0.708 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.339792e-01 | 0.476 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.339792e-01 | 0.476 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.339792e-01 | 0.476 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.339792e-01 | 0.476 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.339792e-01 | 0.476 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.339792e-01 | 0.476 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.339792e-01 | 0.476 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.339792e-01 | 0.476 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.327687e-01 | 0.633 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.327687e-01 | 0.633 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.327687e-01 | 0.633 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.327687e-01 | 0.633 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.718661e-01 | 0.765 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.718661e-01 | 0.765 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.718661e-01 | 0.765 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.718661e-01 | 0.765 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.718661e-01 | 0.765 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.971299e-01 | 0.705 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.701139e-01 | 0.568 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.701139e-01 | 0.568 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.701139e-01 | 0.568 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.701139e-01 | 0.568 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.874911e-01 | 0.727 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.074082e-01 | 0.512 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.074082e-01 | 0.512 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.074082e-01 | 0.512 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.074082e-01 | 0.512 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.499172e-01 | 0.602 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.499172e-01 | 0.602 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.499172e-01 | 0.602 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.080593e-01 | 0.682 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.926935e-01 | 0.715 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.292320e-01 | 0.640 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.292320e-01 | 0.640 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.770576e-01 | 0.557 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.782264e-01 | 0.749 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.509089e-01 | 0.600 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.509089e-01 | 0.600 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.509089e-01 | 0.600 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.509089e-01 | 0.600 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.932838e-01 | 0.714 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.044608e-01 | 0.516 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.915316e-01 | 0.718 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.247402e-01 | 0.648 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.319679e-01 | 0.479 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.054640e-01 | 0.687 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.054640e-01 | 0.687 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.054640e-01 | 0.687 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.884992e-01 | 0.725 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.011729e-01 | 0.696 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.179892e-01 | 0.498 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.179892e-01 | 0.498 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.179892e-01 | 0.498 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.493629e-01 | 0.603 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.045077e-01 | 0.516 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.957756e-01 | 0.529 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.284052e-01 | 0.641 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.080593e-01 | 0.682 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.197663e-01 | 0.658 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.088017e-01 | 0.680 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.274934e-01 | 0.643 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.053653e-01 | 0.687 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.080593e-01 | 0.682 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.800775e-01 | 0.553 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.247402e-01 | 0.648 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.044608e-01 | 0.516 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.088017e-01 | 0.680 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.761988e-01 | 0.754 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.177998e-01 | 0.662 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.080593e-01 | 0.682 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.690695e-01 | 0.570 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.957756e-01 | 0.529 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.821192e-01 | 0.740 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.080593e-01 | 0.682 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.044608e-01 | 0.516 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.493629e-01 | 0.603 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.070370e-01 | 0.684 | 1 | 1 |
| Myogenesis | R-HSA-525793 | 2.284052e-01 | 0.641 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.729908e-01 | 0.564 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.469381e-01 | 0.607 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.884992e-01 | 0.725 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.274934e-01 | 0.643 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.763027e-01 | 0.754 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.965088e-01 | 0.707 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.957878e-01 | 0.708 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.080593e-01 | 0.682 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.509089e-01 | 0.600 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.197663e-01 | 0.658 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.197663e-01 | 0.658 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.577138e-01 | 0.589 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.577138e-01 | 0.589 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.493629e-01 | 0.603 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.761988e-01 | 0.754 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.800775e-01 | 0.553 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.847469e-01 | 0.733 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.773941e-01 | 0.751 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.171389e-01 | 0.663 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.847469e-01 | 0.733 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.509089e-01 | 0.600 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.957878e-01 | 0.708 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.915316e-01 | 0.718 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.327687e-01 | 0.633 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.915316e-01 | 0.718 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.884992e-01 | 0.725 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.088017e-01 | 0.680 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.981610e-01 | 0.526 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.850503e-01 | 0.545 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.838887e-01 | 0.735 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.627412e-01 | 0.580 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.339792e-01 | 0.476 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.339792e-01 | 0.476 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.339792e-01 | 0.476 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.339792e-01 | 0.476 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.971299e-01 | 0.705 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.971299e-01 | 0.705 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.971299e-01 | 0.705 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.874911e-01 | 0.727 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.080593e-01 | 0.682 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.054640e-01 | 0.687 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.658402e-01 | 0.575 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.410582e-01 | 0.618 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.700971e-01 | 0.769 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.805806e-01 | 0.743 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.274934e-01 | 0.643 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.274934e-01 | 0.643 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.746645e-01 | 0.561 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.645960e-01 | 0.577 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.918678e-01 | 0.535 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.800775e-01 | 0.553 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.268630e-01 | 0.486 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.979066e-01 | 0.526 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.853296e-01 | 0.545 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.988803e-01 | 0.525 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.449425e-01 | 0.611 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.637197e-01 | 0.579 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.116588e-01 | 0.506 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.882371e-01 | 0.725 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.903877e-01 | 0.720 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.088017e-01 | 0.680 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.083266e-01 | 0.681 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.241530e-01 | 0.489 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.361483e-01 | 0.627 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.676284e-01 | 0.776 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.249880e-01 | 0.648 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.249880e-01 | 0.648 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.249880e-01 | 0.648 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 3.319679e-01 | 0.479 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.545091e-01 | 0.594 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.096903e-01 | 0.678 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.701139e-01 | 0.568 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.074082e-01 | 0.512 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.729908e-01 | 0.564 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.247402e-01 | 0.648 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.319679e-01 | 0.479 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.410582e-01 | 0.618 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.410582e-01 | 0.618 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.577138e-01 | 0.589 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.433940e-01 | 0.614 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.410582e-01 | 0.618 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.967001e-01 | 0.528 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.701139e-01 | 0.568 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.862260e-01 | 0.730 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.719514e-01 | 0.566 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.627412e-01 | 0.580 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.957878e-01 | 0.708 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.327687e-01 | 0.633 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.268630e-01 | 0.486 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.045077e-01 | 0.516 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.410582e-01 | 0.618 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.448272e-01 | 0.611 | 1 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.866309e-01 | 0.543 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.410582e-01 | 0.618 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.088017e-01 | 0.680 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.074082e-01 | 0.512 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.088017e-01 | 0.680 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.666968e-01 | 0.574 | 1 | 0 |
| Insulin processing | R-HSA-264876 | 2.469381e-01 | 0.607 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.981807e-01 | 0.703 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.915316e-01 | 0.718 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.469381e-01 | 0.607 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.919980e-01 | 0.717 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.676284e-01 | 0.776 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.044608e-01 | 0.516 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.253931e-01 | 0.647 | 1 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.197663e-01 | 0.658 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.493629e-01 | 0.603 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.729908e-01 | 0.564 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.840043e-01 | 0.547 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.292320e-01 | 0.640 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.729908e-01 | 0.564 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.850503e-01 | 0.545 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.083266e-01 | 0.681 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.729908e-01 | 0.564 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.953818e-01 | 0.530 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.874911e-01 | 0.727 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.385090e-01 | 0.470 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.407244e-01 | 0.468 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.423502e-01 | 0.466 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.438541e-01 | 0.464 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.438541e-01 | 0.464 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.439283e-01 | 0.464 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.443129e-01 | 0.463 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.443129e-01 | 0.463 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.443129e-01 | 0.463 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.443129e-01 | 0.463 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.443129e-01 | 0.463 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.443129e-01 | 0.463 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.443129e-01 | 0.463 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.443129e-01 | 0.463 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.443129e-01 | 0.463 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.445716e-01 | 0.463 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.487785e-01 | 0.457 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.531279e-01 | 0.452 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.594339e-01 | 0.444 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.594339e-01 | 0.444 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.594339e-01 | 0.444 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.594339e-01 | 0.444 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.594339e-01 | 0.444 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.594339e-01 | 0.444 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.601042e-01 | 0.444 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.604781e-01 | 0.443 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.623666e-01 | 0.441 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.623666e-01 | 0.441 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.635037e-01 | 0.439 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.637780e-01 | 0.439 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.637780e-01 | 0.439 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.671085e-01 | 0.435 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.695346e-01 | 0.432 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.724840e-01 | 0.429 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.731362e-01 | 0.428 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.778037e-01 | 0.423 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.778037e-01 | 0.423 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.779256e-01 | 0.423 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.802087e-01 | 0.420 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.802087e-01 | 0.420 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.805554e-01 | 0.420 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.805554e-01 | 0.420 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.805554e-01 | 0.420 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.805554e-01 | 0.420 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.805554e-01 | 0.420 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.805554e-01 | 0.420 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.805554e-01 | 0.420 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.805554e-01 | 0.420 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.826874e-01 | 0.417 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.836484e-01 | 0.416 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.862484e-01 | 0.413 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.862484e-01 | 0.413 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.862484e-01 | 0.413 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.867283e-01 | 0.413 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.867283e-01 | 0.413 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.867283e-01 | 0.413 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.927577e-01 | 0.406 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.957001e-01 | 0.403 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.968873e-01 | 0.401 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.983376e-01 | 0.400 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.983376e-01 | 0.400 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.983376e-01 | 0.400 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.983376e-01 | 0.400 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.983376e-01 | 0.400 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.983376e-01 | 0.400 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 3.983376e-01 | 0.400 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.983376e-01 | 0.400 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.983376e-01 | 0.400 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.983376e-01 | 0.400 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.034885e-01 | 0.394 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.047238e-01 | 0.393 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.052579e-01 | 0.392 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.088853e-01 | 0.388 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.088853e-01 | 0.388 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.088853e-01 | 0.388 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.100977e-01 | 0.387 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.100977e-01 | 0.387 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.111020e-01 | 0.386 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.114893e-01 | 0.386 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.120962e-01 | 0.385 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.137348e-01 | 0.383 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.137348e-01 | 0.383 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.137348e-01 | 0.383 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.137348e-01 | 0.383 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.137348e-01 | 0.383 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.137348e-01 | 0.383 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.158842e-01 | 0.381 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.158842e-01 | 0.381 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.159192e-01 | 0.381 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.159192e-01 | 0.381 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.159192e-01 | 0.381 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.174227e-01 | 0.379 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.209041e-01 | 0.376 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.229061e-01 | 0.374 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.232499e-01 | 0.373 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.254230e-01 | 0.371 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.295914e-01 | 0.367 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.313468e-01 | 0.365 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.313468e-01 | 0.365 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.313468e-01 | 0.365 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.313468e-01 | 0.365 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.323259e-01 | 0.364 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.336460e-01 | 0.363 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.336460e-01 | 0.363 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.336460e-01 | 0.363 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.336460e-01 | 0.363 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.397399e-01 | 0.357 | 1 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.403508e-01 | 0.356 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.403508e-01 | 0.356 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.403508e-01 | 0.356 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.403508e-01 | 0.356 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.403508e-01 | 0.356 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.403508e-01 | 0.356 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.403508e-01 | 0.356 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.403508e-01 | 0.356 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.428872e-01 | 0.354 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.428872e-01 | 0.354 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.428872e-01 | 0.354 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.428872e-01 | 0.354 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.442059e-01 | 0.352 | 1 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.502359e-01 | 0.347 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.502359e-01 | 0.347 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.502359e-01 | 0.347 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.502359e-01 | 0.347 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.513123e-01 | 0.346 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.513123e-01 | 0.346 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.513123e-01 | 0.346 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.513123e-01 | 0.346 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.535708e-01 | 0.343 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.535708e-01 | 0.343 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.535708e-01 | 0.343 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.538950e-01 | 0.343 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.564804e-01 | 0.341 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.564804e-01 | 0.341 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.564804e-01 | 0.341 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.564804e-01 | 0.341 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.564804e-01 | 0.341 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.564804e-01 | 0.341 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.564804e-01 | 0.341 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.564804e-01 | 0.341 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.564804e-01 | 0.341 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.564804e-01 | 0.341 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.664868e-01 | 0.331 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.664868e-01 | 0.331 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.688516e-01 | 0.329 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.755008e-01 | 0.323 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.755008e-01 | 0.323 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.816222e-01 | 0.317 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.833777e-01 | 0.316 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.833777e-01 | 0.316 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.833777e-01 | 0.316 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.833777e-01 | 0.316 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.833777e-01 | 0.316 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.833777e-01 | 0.316 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.833777e-01 | 0.316 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.833777e-01 | 0.316 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.833777e-01 | 0.316 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.833777e-01 | 0.316 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.848768e-01 | 0.314 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.920659e-01 | 0.308 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.920659e-01 | 0.308 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.920659e-01 | 0.308 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.970863e-01 | 0.304 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.970863e-01 | 0.304 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.970863e-01 | 0.304 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.970863e-01 | 0.304 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.970863e-01 | 0.304 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.980762e-01 | 0.303 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.034331e-01 | 0.298 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.034331e-01 | 0.298 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.034331e-01 | 0.298 | 0 | 0 |
| Translation | R-HSA-72766 | 5.036178e-01 | 0.298 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.057515e-01 | 0.296 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.077530e-01 | 0.294 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.090075e-01 | 0.293 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.090075e-01 | 0.293 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.090075e-01 | 0.293 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.090075e-01 | 0.293 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.090075e-01 | 0.293 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.090075e-01 | 0.293 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.090075e-01 | 0.293 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.090075e-01 | 0.293 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.090075e-01 | 0.293 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.090075e-01 | 0.293 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.090075e-01 | 0.293 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.090075e-01 | 0.293 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.090075e-01 | 0.293 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.090075e-01 | 0.293 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.128122e-01 | 0.290 | 1 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.139522e-01 | 0.289 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.152512e-01 | 0.288 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.152512e-01 | 0.288 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.152512e-01 | 0.288 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.152512e-01 | 0.288 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.152512e-01 | 0.288 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.153484e-01 | 0.288 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.170227e-01 | 0.286 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.182819e-01 | 0.285 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.182819e-01 | 0.285 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.193901e-01 | 0.285 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.193901e-01 | 0.285 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.214004e-01 | 0.283 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.374831e-01 | 0.270 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.378300e-01 | 0.269 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.390477e-01 | 0.268 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.393451e-01 | 0.268 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.413030e-01 | 0.267 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.413030e-01 | 0.267 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 5.413030e-01 | 0.267 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.413030e-01 | 0.267 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.413030e-01 | 0.267 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.457921e-01 | 0.263 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.457921e-01 | 0.263 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.457921e-01 | 0.263 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.457921e-01 | 0.263 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.457921e-01 | 0.263 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.457921e-01 | 0.263 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.497114e-01 | 0.260 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.521189e-01 | 0.258 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.536757e-01 | 0.257 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.564611e-01 | 0.255 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.564611e-01 | 0.255 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.564611e-01 | 0.255 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.564611e-01 | 0.255 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.564611e-01 | 0.255 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.564611e-01 | 0.255 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.564611e-01 | 0.255 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.564611e-01 | 0.255 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.564611e-01 | 0.255 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.564611e-01 | 0.255 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.564611e-01 | 0.255 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.564611e-01 | 0.255 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.564611e-01 | 0.255 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.564611e-01 | 0.255 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.564611e-01 | 0.255 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.564611e-01 | 0.255 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.585796e-01 | 0.253 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.593489e-01 | 0.252 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.593489e-01 | 0.252 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.593489e-01 | 0.252 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.593489e-01 | 0.252 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.606234e-01 | 0.251 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.648625e-01 | 0.248 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.749602e-01 | 0.240 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.749602e-01 | 0.240 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.749602e-01 | 0.240 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.749602e-01 | 0.240 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.773135e-01 | 0.239 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.791557e-01 | 0.237 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.870796e-01 | 0.231 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.870796e-01 | 0.231 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.876662e-01 | 0.231 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.876662e-01 | 0.231 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.876662e-01 | 0.231 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.876662e-01 | 0.231 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.876662e-01 | 0.231 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.876662e-01 | 0.231 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.984427e-01 | 0.223 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.984427e-01 | 0.223 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.984427e-01 | 0.223 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.984427e-01 | 0.223 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.990266e-01 | 0.223 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.993309e-01 | 0.222 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.993309e-01 | 0.222 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.993309e-01 | 0.222 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.993309e-01 | 0.222 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.993309e-01 | 0.222 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.993309e-01 | 0.222 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.993309e-01 | 0.222 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.993309e-01 | 0.222 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.993309e-01 | 0.222 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.993309e-01 | 0.222 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.993309e-01 | 0.222 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.993309e-01 | 0.222 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.993309e-01 | 0.222 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 5.993309e-01 | 0.222 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.993309e-01 | 0.222 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.993309e-01 | 0.222 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.027357e-01 | 0.220 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.027357e-01 | 0.220 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.027357e-01 | 0.220 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.027357e-01 | 0.220 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.027357e-01 | 0.220 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.027357e-01 | 0.220 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.027357e-01 | 0.220 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.027357e-01 | 0.220 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.060959e-01 | 0.217 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.096875e-01 | 0.215 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.096875e-01 | 0.215 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.100849e-01 | 0.215 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.107831e-01 | 0.214 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.148674e-01 | 0.211 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.167457e-01 | 0.210 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.171893e-01 | 0.210 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.245846e-01 | 0.204 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.272091e-01 | 0.203 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.291152e-01 | 0.201 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.291152e-01 | 0.201 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.291152e-01 | 0.201 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.291152e-01 | 0.201 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.309074e-01 | 0.200 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.309074e-01 | 0.200 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.317054e-01 | 0.199 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.353786e-01 | 0.197 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.353786e-01 | 0.197 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.376627e-01 | 0.195 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.380595e-01 | 0.195 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.380595e-01 | 0.195 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.380595e-01 | 0.195 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.380595e-01 | 0.195 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.380595e-01 | 0.195 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.380595e-01 | 0.195 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.380595e-01 | 0.195 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.380595e-01 | 0.195 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.380595e-01 | 0.195 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.380595e-01 | 0.195 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.380595e-01 | 0.195 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.380595e-01 | 0.195 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.380595e-01 | 0.195 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.380595e-01 | 0.195 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.380595e-01 | 0.195 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.380595e-01 | 0.195 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.380595e-01 | 0.195 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.393377e-01 | 0.194 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.450235e-01 | 0.190 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.502265e-01 | 0.187 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.519468e-01 | 0.186 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.541090e-01 | 0.184 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.541090e-01 | 0.184 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.541090e-01 | 0.184 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.541090e-01 | 0.184 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.541090e-01 | 0.184 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.564079e-01 | 0.183 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.583377e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.682162e-01 | 0.175 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.700380e-01 | 0.174 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.700380e-01 | 0.174 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.700380e-01 | 0.174 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 6.709002e-01 | 0.173 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.716535e-01 | 0.173 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.730466e-01 | 0.172 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.730466e-01 | 0.172 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.730466e-01 | 0.172 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.730466e-01 | 0.172 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.730466e-01 | 0.172 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.730466e-01 | 0.172 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.730466e-01 | 0.172 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.730466e-01 | 0.172 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.730466e-01 | 0.172 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.730466e-01 | 0.172 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.730466e-01 | 0.172 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.730466e-01 | 0.172 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.777385e-01 | 0.169 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.777385e-01 | 0.169 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.777385e-01 | 0.169 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.777385e-01 | 0.169 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.777385e-01 | 0.169 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.777385e-01 | 0.169 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.777385e-01 | 0.169 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.887980e-01 | 0.162 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.896665e-01 | 0.161 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.896665e-01 | 0.161 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 6.896665e-01 | 0.161 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.000340e-01 | 0.155 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.000340e-01 | 0.155 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.000340e-01 | 0.155 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.023589e-01 | 0.153 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.025964e-01 | 0.153 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.046535e-01 | 0.152 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.046535e-01 | 0.152 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.046535e-01 | 0.152 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.046535e-01 | 0.152 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.046535e-01 | 0.152 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.046535e-01 | 0.152 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.046535e-01 | 0.152 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.046535e-01 | 0.152 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.046535e-01 | 0.152 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.046535e-01 | 0.152 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.046535e-01 | 0.152 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.046535e-01 | 0.152 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.046535e-01 | 0.152 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.046535e-01 | 0.152 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.046535e-01 | 0.152 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.046535e-01 | 0.152 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.046535e-01 | 0.152 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.046535e-01 | 0.152 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.046535e-01 | 0.152 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.064447e-01 | 0.151 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.076164e-01 | 0.150 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.123582e-01 | 0.147 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.141848e-01 | 0.146 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.176366e-01 | 0.144 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.210324e-01 | 0.142 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.247582e-01 | 0.140 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.247582e-01 | 0.140 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.323278e-01 | 0.135 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.323278e-01 | 0.135 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.332067e-01 | 0.135 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.332067e-01 | 0.135 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.332067e-01 | 0.135 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.332067e-01 | 0.135 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 7.332067e-01 | 0.135 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.332067e-01 | 0.135 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.332067e-01 | 0.135 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.332067e-01 | 0.135 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.332067e-01 | 0.135 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.332067e-01 | 0.135 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.332067e-01 | 0.135 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.332067e-01 | 0.135 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.365314e-01 | 0.133 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.407762e-01 | 0.130 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.407762e-01 | 0.130 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.407762e-01 | 0.130 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.407762e-01 | 0.130 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 7.407762e-01 | 0.130 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.464370e-01 | 0.127 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.464370e-01 | 0.127 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.475287e-01 | 0.126 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.497142e-01 | 0.125 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.575190e-01 | 0.121 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.587061e-01 | 0.120 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.587061e-01 | 0.120 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.590010e-01 | 0.120 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.590010e-01 | 0.120 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.590010e-01 | 0.120 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.590010e-01 | 0.120 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.590010e-01 | 0.120 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.590010e-01 | 0.120 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.590010e-01 | 0.120 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.590010e-01 | 0.120 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.590010e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.593115e-01 | 0.120 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.593115e-01 | 0.120 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.655397e-01 | 0.116 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.689549e-01 | 0.114 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.714663e-01 | 0.113 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.714663e-01 | 0.113 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.714663e-01 | 0.113 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.729365e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.766875e-01 | 0.110 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.766875e-01 | 0.110 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.766875e-01 | 0.110 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.766875e-01 | 0.110 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.771242e-01 | 0.110 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.823027e-01 | 0.107 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.823027e-01 | 0.107 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.823027e-01 | 0.107 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.823027e-01 | 0.107 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.823027e-01 | 0.107 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.823027e-01 | 0.107 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.823027e-01 | 0.107 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.823027e-01 | 0.107 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.823027e-01 | 0.107 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.823027e-01 | 0.107 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.823027e-01 | 0.107 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.855205e-01 | 0.105 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.929550e-01 | 0.101 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.929550e-01 | 0.101 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.929550e-01 | 0.101 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.929550e-01 | 0.101 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.929550e-01 | 0.101 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.929550e-01 | 0.101 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.929550e-01 | 0.101 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.972061e-01 | 0.098 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.972061e-01 | 0.098 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.972061e-01 | 0.098 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.980017e-01 | 0.098 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 7.988508e-01 | 0.098 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.995880e-01 | 0.097 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.008579e-01 | 0.096 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.032440e-01 | 0.095 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.033527e-01 | 0.095 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.033527e-01 | 0.095 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.033527e-01 | 0.095 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.033527e-01 | 0.095 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.033527e-01 | 0.095 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.033527e-01 | 0.095 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.033527e-01 | 0.095 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.033527e-01 | 0.095 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.033527e-01 | 0.095 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.033527e-01 | 0.095 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.033527e-01 | 0.095 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.033527e-01 | 0.095 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.033527e-01 | 0.095 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.033527e-01 | 0.095 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.081659e-01 | 0.092 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.081659e-01 | 0.092 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.081659e-01 | 0.092 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.092345e-01 | 0.092 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.114798e-01 | 0.091 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.133532e-01 | 0.090 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.154233e-01 | 0.089 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.193378e-01 | 0.087 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.223685e-01 | 0.085 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.223685e-01 | 0.085 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.223685e-01 | 0.085 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.223685e-01 | 0.085 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.223685e-01 | 0.085 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.223685e-01 | 0.085 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.223685e-01 | 0.085 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.223685e-01 | 0.085 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.223724e-01 | 0.085 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.223724e-01 | 0.085 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.223724e-01 | 0.085 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.223724e-01 | 0.085 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.223724e-01 | 0.085 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.223724e-01 | 0.085 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.223724e-01 | 0.085 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.223724e-01 | 0.085 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.285165e-01 | 0.082 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.285165e-01 | 0.082 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.295580e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.347289e-01 | 0.078 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.356264e-01 | 0.078 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.356264e-01 | 0.078 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.356264e-01 | 0.078 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.356264e-01 | 0.078 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.356264e-01 | 0.078 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.375470e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.379140e-01 | 0.077 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.395464e-01 | 0.076 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.395464e-01 | 0.076 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.395464e-01 | 0.076 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.395464e-01 | 0.076 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.395464e-01 | 0.076 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.395464e-01 | 0.076 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.395464e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.395464e-01 | 0.076 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.395464e-01 | 0.076 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.395464e-01 | 0.076 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.395464e-01 | 0.076 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.395464e-01 | 0.076 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.395464e-01 | 0.076 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.395464e-01 | 0.076 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.395464e-01 | 0.076 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.395464e-01 | 0.076 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.395464e-01 | 0.076 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.409496e-01 | 0.075 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.453983e-01 | 0.073 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.453983e-01 | 0.073 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.479792e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.479792e-01 | 0.072 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.526448e-01 | 0.069 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.550640e-01 | 0.068 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.550640e-01 | 0.068 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.550640e-01 | 0.068 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.550640e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.550640e-01 | 0.068 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.550640e-01 | 0.068 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.550640e-01 | 0.068 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.550640e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.554642e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.554642e-01 | 0.068 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.576297e-01 | 0.067 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.576297e-01 | 0.067 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.578854e-01 | 0.067 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.579151e-01 | 0.067 | 1 | 1 |
| Signaling by NTRKs | R-HSA-166520 | 8.593565e-01 | 0.066 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.594812e-01 | 0.066 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.594812e-01 | 0.066 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.594812e-01 | 0.066 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.649520e-01 | 0.063 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.660467e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.664717e-01 | 0.062 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.666948e-01 | 0.062 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.686530e-01 | 0.061 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.690818e-01 | 0.061 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.690818e-01 | 0.061 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.690818e-01 | 0.061 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.690818e-01 | 0.061 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.690818e-01 | 0.061 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.690818e-01 | 0.061 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.690818e-01 | 0.061 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.690818e-01 | 0.061 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.690818e-01 | 0.061 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.690818e-01 | 0.061 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.701813e-01 | 0.060 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.738870e-01 | 0.059 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.801270e-01 | 0.055 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.801270e-01 | 0.055 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.801270e-01 | 0.055 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.817445e-01 | 0.055 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.817445e-01 | 0.055 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.817445e-01 | 0.055 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.817445e-01 | 0.055 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.838375e-01 | 0.054 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.840318e-01 | 0.054 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.877148e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.893641e-01 | 0.051 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.901980e-01 | 0.051 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.918774e-01 | 0.050 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.922521e-01 | 0.050 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.931832e-01 | 0.049 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.931832e-01 | 0.049 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.931832e-01 | 0.049 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.931832e-01 | 0.049 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.931832e-01 | 0.049 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.931832e-01 | 0.049 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.931832e-01 | 0.049 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.931832e-01 | 0.049 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.976230e-01 | 0.047 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.979366e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.979366e-01 | 0.047 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.979366e-01 | 0.047 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.019882e-01 | 0.045 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.035160e-01 | 0.044 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.035160e-01 | 0.044 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.035160e-01 | 0.044 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.035160e-01 | 0.044 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.035160e-01 | 0.044 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.035160e-01 | 0.044 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.045927e-01 | 0.044 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.080588e-01 | 0.042 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.111304e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.128498e-01 | 0.040 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.128498e-01 | 0.040 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.128498e-01 | 0.040 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.128498e-01 | 0.040 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.128498e-01 | 0.040 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.128498e-01 | 0.040 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.128498e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.132542e-01 | 0.039 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.132542e-01 | 0.039 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.132542e-01 | 0.039 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.137931e-01 | 0.039 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.137931e-01 | 0.039 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.144346e-01 | 0.039 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.152489e-01 | 0.038 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.172584e-01 | 0.038 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.184888e-01 | 0.037 | 1 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.200778e-01 | 0.036 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.200778e-01 | 0.036 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.200778e-01 | 0.036 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.200778e-01 | 0.036 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.200778e-01 | 0.036 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.205776e-01 | 0.036 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.209484e-01 | 0.036 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.212812e-01 | 0.036 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.212812e-01 | 0.036 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.212812e-01 | 0.036 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.212812e-01 | 0.036 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.212812e-01 | 0.036 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.212812e-01 | 0.036 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.212812e-01 | 0.036 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.212812e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.212812e-01 | 0.036 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.212812e-01 | 0.036 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.243127e-01 | 0.034 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.243127e-01 | 0.034 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.243127e-01 | 0.034 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.253594e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.263935e-01 | 0.033 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.263935e-01 | 0.033 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.288973e-01 | 0.032 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.288973e-01 | 0.032 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.288973e-01 | 0.032 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.288973e-01 | 0.032 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.288973e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.288973e-01 | 0.032 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.322358e-01 | 0.030 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.322358e-01 | 0.030 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.322358e-01 | 0.030 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.333984e-01 | 0.030 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.352516e-01 | 0.029 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.352516e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.357770e-01 | 0.029 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.357770e-01 | 0.029 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.357770e-01 | 0.029 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.357770e-01 | 0.029 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.357770e-01 | 0.029 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.357770e-01 | 0.029 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.357770e-01 | 0.029 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.357770e-01 | 0.029 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.376371e-01 | 0.028 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.376371e-01 | 0.028 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.380980e-01 | 0.028 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.419541e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.419914e-01 | 0.026 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.419914e-01 | 0.026 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.419914e-01 | 0.026 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.419914e-01 | 0.026 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.419914e-01 | 0.026 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.419914e-01 | 0.026 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.419914e-01 | 0.026 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.419914e-01 | 0.026 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.419914e-01 | 0.026 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.420760e-01 | 0.026 | 1 | 0 |
| Kidney development | R-HSA-9830369 | 9.457349e-01 | 0.024 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.465898e-01 | 0.024 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.472375e-01 | 0.024 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.472375e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.472375e-01 | 0.024 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.476048e-01 | 0.023 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.476048e-01 | 0.023 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.476048e-01 | 0.023 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.476048e-01 | 0.023 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.476048e-01 | 0.023 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.479161e-01 | 0.023 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.514924e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.520272e-01 | 0.021 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.520272e-01 | 0.021 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.526753e-01 | 0.021 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.526753e-01 | 0.021 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.526753e-01 | 0.021 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.554183e-01 | 0.020 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.557642e-01 | 0.020 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.563742e-01 | 0.019 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.563742e-01 | 0.019 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.563742e-01 | 0.019 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.572553e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.572553e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.572553e-01 | 0.019 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.572553e-01 | 0.019 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.572553e-01 | 0.019 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.575654e-01 | 0.019 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.587075e-01 | 0.018 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.590390e-01 | 0.018 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.599479e-01 | 0.018 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.613924e-01 | 0.017 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.613924e-01 | 0.017 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.613924e-01 | 0.017 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.613924e-01 | 0.017 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.623767e-01 | 0.017 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.636280e-01 | 0.016 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.651293e-01 | 0.015 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.651293e-01 | 0.015 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.659962e-01 | 0.015 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.659962e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.661967e-01 | 0.015 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.664844e-01 | 0.015 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.682852e-01 | 0.014 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.682852e-01 | 0.014 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.684990e-01 | 0.014 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.685046e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.685046e-01 | 0.014 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.685046e-01 | 0.014 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.685046e-01 | 0.014 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.687576e-01 | 0.014 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.692477e-01 | 0.014 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.706823e-01 | 0.013 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.715535e-01 | 0.013 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.715535e-01 | 0.013 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.715535e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.715535e-01 | 0.013 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.743073e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.743073e-01 | 0.011 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.743073e-01 | 0.011 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.747307e-01 | 0.011 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.750029e-01 | 0.011 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.757220e-01 | 0.011 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.766078e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.767947e-01 | 0.010 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.767947e-01 | 0.010 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.772148e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.788050e-01 | 0.009 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.790415e-01 | 0.009 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.791497e-01 | 0.009 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.794033e-01 | 0.009 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.811204e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.811204e-01 | 0.008 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.829037e-01 | 0.007 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.829037e-01 | 0.007 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.845593e-01 | 0.007 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.845593e-01 | 0.007 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.860546e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.860546e-01 | 0.006 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.866786e-01 | 0.006 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.874052e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.886250e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.886250e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.897268e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.897268e-01 | 0.004 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.897268e-01 | 0.004 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.897957e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.902511e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.907219e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.916207e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.916207e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.916207e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.921835e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.921835e-01 | 0.003 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.922494e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.924325e-01 | 0.003 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.928505e-01 | 0.003 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.930141e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.931656e-01 | 0.003 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.931656e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.931656e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.931656e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.931656e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.931656e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.933183e-01 | 0.003 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.934618e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.935934e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.935934e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.938278e-01 | 0.003 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.940683e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.941876e-01 | 0.003 | 1 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.944259e-01 | 0.002 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.945346e-01 | 0.002 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.945346e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.946880e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.949660e-01 | 0.002 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.949676e-01 | 0.002 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.950043e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.954538e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.954538e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.957852e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.959325e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.963863e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.966517e-01 | 0.001 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.966620e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.968192e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.969762e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.970951e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.972447e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.974126e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.975340e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.975780e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.979181e-01 | 0.001 | 1 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.979817e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.981840e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983588e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.983601e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.984660e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.984660e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.984660e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.986279e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.986627e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.988354e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.988906e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.989095e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.989095e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.990153e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.990784e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.991108e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991108e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.992691e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992749e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.992749e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993453e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995180e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.995180e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.995647e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.995787e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.996378e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.996815e-01 | 0.000 | 1 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.996818e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997107e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997107e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997811e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998039e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.998044e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.998432e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998584e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998692e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998866e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999076e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999151e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999375e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999414e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999559e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999724e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999726e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999757e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999808e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999894e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999910e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999922e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999948e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999951e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999957e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999964e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999971e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999976e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999976e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999987e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999990e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999995e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |